Electrosurgical device

Description

FIELD OF THE INVENTION

The present invention relates generally to methods and devices usable within the body of a patient to deliver energy to tissue. More specifically, the present invention is concerned with medical devices which use electricity for puncturing tissue.

SUMMARY OF THE DISCLOSURE

Mechanical force is typically used with a conventional transseptal needles to create a puncture. Under certain circumstances, however, mechanical force is not always effective at puncturing tissue. In such cases a physician may use electrical energy to create a puncture while having sufficient stiffness in the puncture device to provide tactile feedback, i.e. to use an electrosurgical device which is stiff. These requirements could be met by an electrosurgical device comprising an electrically conductive elongate member which is capable of force transmission from a distal portion of the electrosurgical device to a proximal portion of the electrosurgical device to thereby provide tactile feedback to a user, wherein the proximal portion comprises a handle with the handle including an electrical connector which is configured to receive, in a releasable manner, an electrically conductive component operable to be electrically coupled to an energy source.

In a first broad aspect, embodiments of the present invention comprise an electrosurgical device having an electrically conductive elongate member, wherein the device defines a proximal portion and a distal portion, with the electrically conductive elongate member being capable of force transmission from the distal portion to the proximal portion to thereby provide tactile feedback to a user. The proximal portion comprises a handle, with the handle including an electrical connector which is configured to receive, in a releasable manner, an electrically conductive component operable to be electrically coupled to an energy source.

As features of the first broad aspect: some embodiments have a distal tip including an electrode for delivering energy to a tissue; some embodiments include the handle having insulation for electrically insulating a user from the electrically conductive elongate member; some embodiments include the handle having ridges for enhancing grip and tactile feedback; some embodiments include the electrically conductive elongate member defining a lumen and the handle having a fluid connector for connecting the lumen to a source of fluid, with some of said embodiments having a distal end of the electrically conductive elongate member defining a distal aperture which is in fluid communication with the lumen.

As a feature of the first broad aspect, some embodiments comprise the electrical connector being electrically coupled to the electrically conductive elongate member, in some examples, through the handle Some embodiments of this feature include the handle comprising a conductor such as conductive wire or conductive rigid member for electrically coupling the electrical connector to the electrically conductive elongate member.

As another feature of the first broad aspect, in some embodiments the electrical connector comprises a jack for receiving the electrically conductive component. Some of said embodiments further comprise a conductive wire extending from the handle to the jack, wherein the jack is electrically connected to an end of the wire such that the conductive wire electrically couples the jack to the handle.

Some embodiments of the first broad aspect include a force transmitting portion which extends between a distal portion of the electrosurgical device and a proximal portion of the electrosurgical device. In some of these embodiments, the force transmitting portion has a flexural rigidity of at least about 0.016 Nm2.

As a feature of the first broad aspect, some embodiments of the handle comprise a hub. Some embodiments having this feature comprise a distal tip which includes an electrode for delivering energy to a tissue. In some embodiments, the hub comprises electrical insulation for insulating a user from the electrically conductive elongate member. In some embodiments having this feature, the hub comprises ridges for enhancing grip and tactile feedback. In some examples, the electrically conductive elongate member defines a lumen, and the hub includes a fluid connector for connecting the lumen to a source of fluid. Some such examples include a distal end of the electrically conductive elongate member defining a distal aperture which is in fluid communication with the lumen. Some embodiments include the electrical connector being electrically coupled to the electrically conductive elongate member, with some such embodiments further comprising a conductive wire for electrically coupling the electrical connector to the electrically conductive elongate member.

In some embodiments wherein the handle comprises a hub, the electrical connector comprises a jack for receiving the electrically conductive component, with some such embodiments further comprising a conductive wire extending from the hub and the jack being electrically connected to a distal end of the wire such that the conductive wire electrically couples the jack to the hub. Some embodiments of this feature include a force transmitting portion which extends between a distal portion of the electrosurgical device and a proximal portion of the electrosurgical device. In some such embodiments, the force transmitting portion has a flexural rigidity of at least about 0.016 Nm2.

In a second broad aspect, embodiments of the present invention include a transseptal puncturing device comprising an electrically conductive elongate member and an electrode at a distal end of the electrically conductive elongate member for delivering energy to tissue, the transseptal puncturing device further including an electrical connector configured to receive, in a releasable manner, an electrically conductive component operable to be electrically coupled to an energy source.

As a feature of the second broad aspect, some embodiments include the electrically conductive elongate member defining a lumen and the transseptal puncturing device further comprising a handle which includes a fluid connector for connecting the lumen to a source of fluid. Some such embodiments include a distal portion of the transseptal puncturing device defining a distal aperture in fluid communication with the lumen.

Some embodiments of the second broad aspect include the transseptal puncturing device having an electrical insulation extending proximally from the electrode. Some embodiments include a distal tip of the transseptal puncturing device being substantially atraumatic. Some examples of the second broad aspect further comprise a handle having electrical insulation for insulating a user from the electrically conductive elongate member. In some such examples, the handle comprises ridges for enhancing tactile feedback.

Some embodiments of the second broad aspect include the electrical connector being electrically coupled to the electrically conductive elongate member. Some such embodiments further comprise a conductive wire for electrically coupling the electrical connector to the electrically conductive elongate member. In some examples of the second broad aspect, the electrical connector comprises a jack for receiving the electrically conductive component.

In a third broad aspect, embodiments of the present invention are for a method of using a transseptal puncturing device comprising an elongate member which is electrically conductive, an electrical connector in electrical communication with the elongate member, and an electrode at a distal end of the elongate member for delivering energy to tissue, the method comprising the steps of (1)) connecting an electrically conductive component, which is in electrical communication with a source of energy, to the electrical connector, and (2) delivering electrical energy through the electrode to a tissue.

As a feature of the third broad aspect, some embodiments further comprise a step (3) of disconnecting the electrically conductive component from the electrical connector i.e. the electrically conductive component is releasably connected to the electrical connector.

In a fourth broad aspect, embodiments of the present invention include an electrosurgical device comprising an electrically conductive elongate member, with the device defining a proximal portion and a distal portion. The electrically conductive elongate member is capable of force transmission from the distal portion to the proximal portion to thereby provide tactile feedback to a user. The proximal portion comprises a handle, the handle having a connector means for receiving, in a releasable manner, an electrically conductive component, wherein the electrically conductive component is operable to be electrically coupled to an energy source.

BRIEF DESCRIPTION OF THE DRAWINGS

In order that the invention may be readily understood, embodiments of the invention are illustrated by way of examples in the accompanying drawings.

FIG. 1 illustrates a perspective view of a medical device in accordance with an embodiment of the present invention;

FIGS. 2A to 2D illustrate partial perspective views of distal regions of embodiments of medical devices;

FIG. 2E illustrates a cross-sectional view of a distal region of an embodiment of a medical device;

FIGS. 3A to 3D illustrate perspective views of various electrode configurations;

FIGS. 4A and 4B illustrate a partially cut-away side view and an end view, respectively, of a medical device and a tubular member in accordance with an embodiment of the present invention;

FIGS. 5A and 5B illustrate a partially cut-away side view and an end view, respectively, of a medical device and a tubular member in accordance with another embodiment of the present invention;

FIGS. 5C and 5D illustrate end views of a medical device and a tubular member in accordance with alternative embodiments of the present invention;

FIGS. 6A and 6B illustrate a partially cut-away side view and an end view, respectively, of a tubular member in accordance with another embodiment of the present invention;

FIGS. 7A and 7B illustrate a partially cut-away side view and an end view, respectively, of a medical device and a tubular member in accordance with another embodiment of the present invention;

FIG. 8 illustrates a perspective view of a system including a medical device in accordance with the present invention;

FIGS. 9A and 9B illustrate partially cut-away views of a method using an apparatus in accordance with an embodiment of the present invention;

FIG. 10A illustrates a perspective view of an elongate member portion of the medical device shown in FIG. 1;

FIG. 10B illustrates a partial perspective view of an alternative elongate member usable in the medical device shown in FIG. 1;

FIG. 10C illustrates a partial perspective view of another alternative elongate member usable in the medical device shown in FIG. 1;

FIG. 10D illustrates a partial perspective view of yet another alternative elongate member usable in the medical device shown in FIG. 1;

FIG. 11A illustrates a perspective view of a medical device in accordance with an yet another alternative embodiment of the present invention, the medical device including a curved section;

FIG. 11B illustrates a partial perspective view of a medical device in accordance with yet another alternative embodiment of the present invention, the medical device including an alternative curved section;

FIG. 11C illustrates a partial perspective view of a medical device in accordance with yet another alternative embodiment of the present invention, the medical device including another alternative curved section;

FIG. 12A illustrates a top elevation view of an embodiment of a hub; and

FIG. 12B illustrates a side cross-sectional view taken along the line 5B-5B of FIG. 12A.

DETAILED DESCRIPTION

Devices used for puncturing tissue, such as the septal tissue of a patient's heart, are typically either mechanical or electrosurgical in nature. Usually, such devices are inserted into a patient's body through tubular devices such as dilators or sheaths. Mechanical force is normally used with a conventional Brockenbrough transseptal needle to create a puncture. A Brockenbrough needle has a sharp beveled tip and a forward-facing aperture that may be used for injecting fluid or monitoring pressure. Under certain circumstances, however, mechanical force is not always effective at puncturing tissue. In such cases, physicians have proposed using an electrocautery generator or the like to electrify the mechanical needle and thereby produce an ad hoc electrosurgical device with a forward facing aperture. One drawback to electrifying a non-insulated Brockenbrough needle is a risk of burns to the patient and physician. While a dilator or sheath provides some insulation for the part of the non-insulated Brockenbrough needle contained therein, there is still potential for burns to the patient and physician by sections of the needle outside of the dilator or sheath. Also, any fluids (e.g. blood, cooling water) inside of the dilator or sheath will be exposed to electricity such that the fluid may conduct electricity to outside of the dilator or sheath. Furthermore, there is a risk of tissue coring. A core (or plug) of tissue is typically cut from the tissue inside the ring-shaped distal tip of the needle upon delivery of energy. This tissue core is subsequently captured in the lumen of the electrosurgical device upon advancement of the needle through tissue. The tissue core may be released from the lumen, potentially leading to emboli and increasing the risk of a stroke or other ischemic event.

The present inventors have conceived of, and reduced to practice embodiments of an electrosurgical device configured for force transmission from a distal portion of the electrosurgical device to a proximal portion of the electrosurgical device to thereby provide tactile feedback to a user. The proximal portion of the device comprises a handle and/or a hub, with the handle (or hub) including an electrical connector which is configured to receive, in a releasable manner, an electrically conductive component which is operable to be in electrical communication with an energy source to allow the physician or other user to puncture a tissue layer, such as a septum. In some cases, a radiofrequency (RF) energy source is used to selectively apply RF energy to tissue. Typical embodiments of the device include insulation to protect the user and the patient, and are configured to avoid creating emboli. Some embodiments comprise a transseptal puncturing device having an electrically conductive elongate member and an electrode at a distal end of the electrically conductive elongate member for delivering energy to tissue, with the transseptal puncturing device further including an electrical connector configured to releasably receive, the electrically conductive component which is electrically coupled to an energy source.

With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of embodiments of the present invention only. In this regard, no attempt is made to show structural details of the invention in more detail than is necessary for a fundamental understanding of the invention. The description taken with the drawings will make apparent to those skilled in the art how the several aspects of the invention may be embodied in practice.

Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of the components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments or of being practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.

As used herein, the terms ‘proximal’ and ‘distal’ are defined with respect to the user. That is, the term ‘proximal’ refers to a part or portion closer to the user, and the term ‘distal’ refers to a part or portion further away from the user when the device is in use. Also, it should be noted that while, for clarity of explanation, the term tubular or tubular member is used to describe the members that enclose the disclosed medical devices, the term tubular member is intended to describe both circular and non-circular embodiments of the enclosing member. The term tubular member is used in this disclosure to describe dilators, sheaths, and other members that define a lumen for containing a medical device.

Referring to FIG. 1, there is shown a medical device 100 in accordance with an embodiment of the present invention. The medical device 100 is usable for creating a channel at a target location in a body of a patient. The medical device 100 includes a handle 110, a distal portion 112 and a force transmitting portion 114 extending between the distal portion 112 and the handle 110. The distal portion 112 defines a distal portion length, and includes an electrode 106 and an electrical insulation 104 extending proximally from the electrode 106.

The force transmitting portion 114 defines a force transmitting portion length, the force transmitting portion length being larger than the distal portion length. In some embodiments of the invention, the force transmitting portion 114 has a force transmitting portion flexural rigidity of at least about 0.016 Nm2, for example about 0.017 Nm2. The force transmitting portion 114 has a force transmitting portion flexural rigidity allowing the transmission to the handle 110 of contact forces exerted on the distal portion 112 when the distal portion 112 contacts the target location to provide tactile feedback to the intended user. In addition, the force transmitting portion flexural rigidity allows for the transmission of force from the handle 110 to the distal portion 112 in order to, for example, advance the distal portion 112 within the body of the patient or to orient the distal portion 112 by applying torque to the handle 110.

Therefore, the proposed medical device 100 is structured such that it provides the intended user with a similar, or better, ‘feel’ as some prior art devices. That is, although the structure and function of the medical device 100 differs significantly from prior art devices.

In some embodiments of the invention, the distal portion 112 has a distal portion flexural rigidity of at least about 0.0019 Nm2, for example 0.0021 Nm2. Such values of flexural rigidity enhance the cognitive ergonomics of the proposed medical device 100 by providing tactile feedback to the intended user and allowing for the transmission of radial (torque) and longitudinal forces from the handle to the distal portion.

In typical embodiments of the invention, the medical device 100 includes an electrically conductive elongate member 102 having an electrical insulation 104 disposed thereon. The electrical insulation 104 substantially covers the entire outer surface of the elongate member 102 such that elongate member 102 is able to deliver energy from its proximal region to the electrode 106 at its distal region, without substantial leakage of energy along the length of the elongate member 102. The elongate member 102 defines a lumen 208 and at least one side-port 600 (shown, for example, in FIGS. 2A to 2D), which is in fluid communication with the lumen 208.

The one or more side-ports 600 are particularly useful in typical embodiments of medical device 100 wherein a lumen 208 of the elongate member 102 is not open to the surrounding environment via the distal end of the medical device 100 (i.e. wherein medical device 100 is a close-ended device), for example, in the embodiments of FIGS. 2A to 2E. In such embodiments, the lumen extends substantially longitudinally through the force transmitting portion 114 (FIG. 1), and through a section of the distal portion 112, and terminates in the distal portion 112 at a location substantially spaced apart from the distal tip 403, such that the distal tip 403 remains closed.

In embodiments comprising side-port(s) 600, the side-port(s) 600 allow for fluids to be injected into the surrounding environment from the lumen 208, and/or allow for pressure to be measured by providing a pressure transmitting lumen through medical device 100. In some examples, the side-port(s) 600 are formed radially through elongate member 102 and electrical insulation 104, thereby allowing for fluid communication between the surrounding environment and the lumen 208. In alternative embodiments, a side-port 600 is formed radially through a portion of the electrode 106.

The size and shape of the side-port(s) 600 may vary depending on the intended application of the medical device 100, and the invention is not limited in this regard. For example, in one embodiment, the side-port(s) 600 is between about 0.25 mm and about 0.45 mm in diameter. Some embodiments include side-ports of more than one size. In addition, the number of side-ports 600 may vary, and they may be located anywhere along the medical device 100 that does not interfere with the functioning of the device. For example, as shown in FIG. 2A, the medical device 100 includes two side-ports 600 located about 1 cm from the distal end of the elongate member 102, at substantially the same longitudinal position along the elongate member 102. In another embodiment, as shown in FIG. 2B, the medical device 100 includes about 3 side-ports located at the same circumferential position and spaced longitudinally at about 1.0 cm, 1.5 cm, and 2.0 cm from the distal end of the elongate member 102. In another embodiment, as shown in FIG. 2C, the side-ports 600 are staggered, such that they are spaced apart both circumferentially as well as longitudinally. In a further embodiment, as shown in FIG. 2D, the side-ports 600 are located on the electrode 106. In some embodiments, the side-port(s) 600 have a smooth or rounded wall, which serves to minimize or reduce trauma to bodily tissue. For example, some such embodiments comprise one or more side-port(s) 600 with a smooth outer circumferential edge created by sanding the circumferential edges to a smooth finish or, for example, by coating the edges with a lubricious material.

When a medical device that relies on side-ports to provide fluid communication between its lumen and the surrounding environment is inside a lumen of a close fitting member, the side-ports may be partially or completely occluded or blocked. The embodiments of FIGS. 4 to 9 relate to an apparatus that provides an effective conduit from the lumen of medical device to the environment outside of the device, and methods of using such apparatus.

FIGS. 4A and 4B illustrate a partially cut-away side view and an end view, respectively, of a distal portion 112 of medical device 100 positioned within tubular member 800. As described in more detail herein below, some embodiments of medical device 100 are comprised of a single piece elongate member 102 (as shown in FIG. 1 and FIG. 10A) and some other embodiments of medical device 100 are comprised of two elongate members, main member 210 and end member 212, which are joined together (as shown in FIGS. 10D and 2E). Depending on the embodiment of medical device 100 being considered, distal portion 112 may be the distal portion of a single piece elongate member 102, the distal portion of an end member 212, or the distal portion of some other embodiment of medical device 100. In FIGS. 4 to 9, the lumen defined by distal portion 112 may be either lumen 208 of elongate member 102 or end member lumen 216. For descriptive purposes, the lumen defined by distal portion 112 in FIGS. 4 to 9 is referred to as device lumen 809.

Tubular member 800 may comprise a dilator, a sheath, or some other member defining a lumen configured to receive a medical device 100.

Referring to FIGS. 4A and 4B, illustrated features of an embodiment of distal portion 112 of medical device 100 include a change in diameter 831, a distal portion 830, device lumen 809 defined by a body of the medical device 100, a side-port 600 in fluid communication with the lumen, and a closed distal end. Distal portion 830 has an outer diameter less than the outer diameter of distal portion 112 proximal of the change in diameter 831, i.e., distal portion 830 has a reduced diameter. In the embodiment of FIG. 4A, distal tip 403 of the medical device comprises a distal electrode 106. Some alternative embodiments of medical device 100 do not include an electrode. Tubular member 800 defines tubular member lumen 802. Tubular member 800 and distal portion 830 of medical device 100, in combination, define conduit 808 whereby medical device 100 is able to provide sufficient fluid flow for delivering contrast fluid to stain tissue. Fluid (e.g. blood) may also be withdrawn through the path defined by conduit 808, side-port 600, and device lumen 809. In the example of FIG. 4A, conduit 808 includes the space between tubular member 800 and reduced diameter distal portion 830, and the portion of tubular member lumen 802 distal of medical device 100.

In the embodiment of FIG. 4A, distal portion 830 is distal of change in diameter 831 and includes insulated part 834 and electrode 106. Constant diameter part 836 is distal of change in diameter 831 and includes insulated part 834 and the straight longitudinal part of electrode 106 that has a constant diameter (i.e. the portion of electrode proximal of the dome shaped electrode tip). Constant diameter part 836 of distal portion 830 does not taper and may be described as having a substantially constant diameter longitudinally. There is a minor change in outer diameter at the distal end of electrical insulation 104, but with regards to fluid flow, it can be considered negligible.

In the embodiment of FIG. 4A, a small space or gap 832 exists between the tubular member 800 and the part of distal portion 112 proximal of the change in diameter 831. It is common for embodiments of medical device 100 and tubular member 800 to have a small gap 832 between the outer diameter of medical device and the inner diameter of tubular member. Completely eliminating the gap would result in increased friction between the medical device and tubular member and could result in difficulty advancing medical device 100 through tubular member 800. In typical embodiments, the gap is small enough that it prevents a substantial flow of fluids such as contrast fluids, which are typically 3 to 5 times more viscous than water.

In the embodiment of FIG. 4A, side-port 600 is close to the change in diameter 831 whereby the larger diameter part of distal portion 112 functions as a brace to keep tubular member 800 from blocking side-port 600. FIG. 4A illustrates an abrupt change in diameter. Alternative embodiments have a less abrupt change in diameter. Typical embodiments of medical device 100 include a second side-port, with the two side-ports being opposite to each other. Some alternative embodiments include more than two side-ports. Other alternative embodiments have one side-port. In some alternative embodiments of medical device 100, side-port 600 is longitudinally elongated, i.e., capsule-shaped.

The side-port(s) 600 and the device lumen 809 together provide a pressure transmitting lumen. The pressure transmitting lumen is operable to be coupled to a pressure transducer, for example, external pressure transducer 708 (to be described with respect to FIG. 8).

Distal tip 403 of medical device 100 is shown in the example of FIG. 4A as being slightly proximal of the distal end of tubular member 800. In this position, fluid communication between the medical device lumen and the surrounding environment may be established. Fluid communication may also be established when distal tip 403 is positioned further proximal of the distal end of tubular member 800, when distal tip 403 is aligned with the distal end of tubular member 800, and when distal tip 403 is positioned distal of the distal end of tubular member 800. If distal tip 403 is positioned such that side-port 600 is distal of the distal end of tubular member 800, it is still possible to deliver fluid in a radial direction.

Typical embodiments of medical device 100 comprise a conductive member (elongate member 102, or main member 210 joined to end member 212), which is typically comprised of a metallic material. The conductive member is in electrical communication with distal electrode 106, and a layer of insulation (electrical insulation 104) covers the metallic material. In other words, the elongate member 102 comprises an electrically conductive material, and a layer of insulation covers the electrically conductive material, the electrically conductive material being electrically coupled to the electrode 106. For some single piece embodiments, elongate member 102 has an on outer diameter proximal of change in diameter 831 of about 0.7 mm to about 0.8 mm at distal end 206, and an outer diameter for reduced diameter distal portion 830 of about 0.4 mm to about 0.62 mm. For some two piece embodiments, end member 212 has an outer diameter proximal of change in diameter 831 of about 0.40 mm to about 0.80 mm, and an outer diameter for distal portion 830 of about 0.22 mm to about 0.62 mm. The above described embodiments are typically used with a tubular member defining a corresponding lumen about 0.01 mm (0.0005 inches) to about 0.04 mm (0.0015 inches) larger than the outer diameter of medical device 100 proximal of change in diameter 831.

FIG. 4B illustrates an end view of the apparatus of FIG. 4A. The figure includes, from inside to outside (in solid line), electrode 106, electrical insulation 104, the part of distal portion 112 proximal of change in diameter 831, gap 832, tubular member distal end 801, and tubular member 800. Hidden features shown in broken line include side-port 600 and device lumen 809.

In the embodiment of FIGS. 4A and 4B, distal tip 403 of the medical device is comprised of electrode 106 which defines a substantially circular cross-section and a circular end-profile Similar to the embodiments of FIGS. 3A and 3B, electrode 106 of FIG. 4B is at the end of elongate member 102 (or end member 212) and has the same outer diameter as the distal end of the conductive member. Since constant diameter part 836 of reduced diameter distal portion 830 does not substantially taper (the small change in diameter at the distal end of electrical insulation 104 is not taken to be substantial), electrode 106 has a diameter which is substantially equal to the diameter of the part of distal portion 830 which is proximal of electrode 106 (i.e. substantially equal to the diameter of insulated part 834).

Making reference again to FIGS. 1 to 4, some embodiments of medical device 100 comprise an elongate member 102 having a closed distal end, with the elongate member defining a device lumen 809 and at least one side-port 600 in fluid communication with the device lumen. The elongate member also defines a proximal portion and a distal portion 830, the distal portion extending from the at least one side-port 600 to the distal end of the elongate member. The proximal portion defines a first outer diameter and the distal portion defines a second outer diameter, with the first outer diameter being larger than the second outer diameter, and the second outer diameter being substantially constant. The distal tip of medical device 100 comprises an electrode 106. The diameter of the electrode is substantially equal to the second outer diameter.

Some embodiments of electrode 106 typically create a puncture in tissue with a diameter 10 to 20 percent larger than the electrode. Such a puncture diameter is typically large enough to facilitate passage of the part of medical device proximal of change of diameter 831 (i.e. the larger diameter portion of medical device) through the tissue puncture, and to start advancing a dilator over medical device 100 and through the tissue.

FIGS. 5A to 5D illustrate embodiments of medical device 100 wherein distal portion 830 has a non-circular cross section. In FIGS. 5A and 5B, distal portion 830 (including electrode 106 and insulated part 834 (FIG. 4a)) defines a substantially flat outer surface portion. The body of medical device 100 defines device lumen 809 (shown in broken line in FIG. 5B), and side-port 600 in fluid communication with the lumen. Reduced outer diameter distal portion 830 of the body extends between side-port 600 and distal tip 403 of the medical device whereby the outer surface of medical device 100, in combination with tubular member 800 can provide a conduit 808. While FIG. 5A illustrates a portion of reduced outer diameter distal portion 830 extending proximally from side-port 600 to change in diameter 831, some alternative embodiments do not include this portion, i.e., change in diameter 831 is adjacent side-port 600.

The embodiment of conduit 808 in FIG. 5B is shown as having an end-view shape of a portion of circle. The reduced outer diameter is substantially constant longitudinally along distal portion 830, with the exceptions of the distal end of electrical insulation 104 and the hemispherical-shaped distal tip of electrode 106. A cross-section of the electrode 106 is substantially identical to a cross-section of the part of the distal portion 830 which is proximal of the electrode.

FIG. 5C illustrates an alternative embodiment with two flat outer surfaces and two corresponding side-ports. FIG. 5D illustrates another alternative embodiment with three flat outer surfaces and three corresponding side-ports. Further alternative embodiments are similar to the embodiments of FIGS. 5B, 5C and 5D, except instead of the flat outer surfaces, the devices have corresponding outer surfaces that are convexly curved to provide a larger device lumen 809.

FIGS. 6A and 6B illustrate an embodiment of a tubular member 800 for use with a medical device 100 having a side-port 600. The body of tubular member 800 defines a lumen such that tubular member proximal region 803a has a first inner diameter d1, and tubular member distal region 803b has at least a portion of it defining a second inner diameter d2, wherein the second inner diameter d2 is greater than the first inner diameter d1, and wherein the tubular member distal region 803b extends to the tubular member distal end 801.

The embodiment of FIG. 6B includes the tubular member distal region 803b (i.e. the increased diameter portion with the second inner diameter d2) extending circumferentially over less than 360 degrees of the circumference of the tubular member. Tubular member inner surface 804 defines a tubular member channel 805 which, in the example of FIG. 6B, extends circumferentially approximately 90 degrees. In some alternative embodiments, tubular member distal region 803b extends 360 degrees of the circumference of the tubular body.

The embodiment of FIGS. 6A and 6B includes tubular member proximal marker 816 at the proximal end of the distal region, and tubular member distal marker 818 at the distal end of tubular member distal region 803b. Alternative embodiments have only one of the distal region markers or neither distal region marker. The embodiment of FIGS. 6A and 6B also includes a side marker 819, which is operable to be used as an orientation marker for aligning the tubular member distal region 803b (i.e. the increased diameter portion) with the side-port 600 of a medical device 100 positioned inside the tubular member.

One embodiment is a dilator comprising a tubular member defining a lumen in fluid communication with a distal end aperture, a proximal region having a first inner diameter, and a distal region having an increased diameter portion. The increased diameter portion extends proximally from a distal end of the dilator and defines a substantially longitudinally constant second inner diameter that is greater than the first inner diameter.

The embodiment of FIGS. 7A and 7B is a kit comprising a tubular member 800 and a medical device 100, operable to be combined to form an apparatus. Tubular member 800 defines a tubular member lumen 802 for receiving medical device 100. Medical device 100 defines a device lumen 809 in fluid communication with a side-port 600, and comprises a medical device proximal region 838 proximal of the side-port, and a medical device distal region 839 distal of the side-port. Medical device 100 and tubular member 800 are configured for cooperatively forming a conduit 808 between an outer surface of medical device distal region 839 and an inner surface of tubular member 800. In the example of FIG. 7A, conduit 808 is formed both proximal and distal of side-port 600, while in alternative embodiments it is only formed distal of the side-port. In typical use, conduit 808 is formed at least between the side-port and a distal end of the tubular member when medical device 100 is inserted and positioned within tubular member lumen 802.

The apparatus of FIG. 7A includes both a tubular member channel 805 and a medical device channel 807. Conduit 808 is comprised of both tubular member channel 805 and a medical device channel 807. In typical embodiments, at least some of the length of conduit 808 has a constant cross-sectional configuration, which reduces turbulence and facilitates laminar flow, which in turn facilitates forwards injection of a fluid. Some alternative embodiments include a tubular member channel 805 but not a medical device channel 807, and some other alternative embodiments include a medical device channel 807 but not a tubular member channel 805.

Some embodiments of the medical device and the tubular member further comprise corresponding markers for aligning the side-port of the medical device within the tubular member lumen to form said conduit. In the example of FIG. 7, medical device 100 includes medical device proximal marker 810 and medical device distal marker 812, while tubular member 800 includes side marker 819. In some embodiments of the kit, the corresponding markers are configured for longitudinally aligning the side-port within the tubular member lumen. In the example of FIG. 7, side-port 600, which is equidistant between medical device proximal marker 810 and medical device distal marker 812, can be longitudinally aligned with side marker 819 by positioning side marker 819 between medical device proximal marker 810 and medical device distal marker 812.

In some embodiments of the kit, the corresponding markers are configured for rotationally aligning the side-port within the tubular member lumen. In the example of FIG. 7, side-port 600 can be rotationally aligned with side marker 819 of tubular member 800 by comparing the relatively larger diameter medical device proximal marker 810 with the smaller diameter medical device distal marker 812, which thereby aligns side-port 600 with tubular member channel 805. Alternative embodiments of medical device 100 include a side-marker on the same side as side-port 600, or on the side opposite to the side-port, to facilitate rotational positioning. Further details regarding markers are found in U.S. Pat. No. 4,774,949, issued Oct. 4, 1988 to Fogarty, incorporated by reference herein in its entirety.

An embodiment of a kit comprises a tubular member defining a tubular member lumen in fluid communication with a distal end aperture, and a medical device having a closed distal end. The medical device comprises a device lumen in fluid communication with at least one side-port, and a distal portion extending from the at least one side-port to a distal end of the medical device. Medical device and tubular member are configured to cooperatively form a conduit between an outer surface of the distal portion and an inner surface of the tubular member when the medical device is inserted within the tubular member lumen. The conduit extends at least between the side-port and the distal end aperture for enabling fluid communication between the side-port and an environment external to the distal end aperture.

In a specific embodiment of a kit, end member 212 has an on outer diameter proximal of change in diameter 831 of about 0.032 inches (about 0.81 mm), and an outer diameter at reduced diameter distal portion 830 of about 0.020 inches (about 0.51 mm) to about 0.025 inches (about 0.64 mm). End member 212 is used with a tubular member defining a lumen about 0.0325 inches (0.82 mm) to about 0.0335 inches (0.85 mm).

Referring to FIG. 8, systems for use with the medical device 100 typically comprise a generator 700 and, in some embodiments, a grounding pad 702, external tubing 706, a pressure transducer 708, and/or a source of fluid 712.

Referring to FIG. 8, as mentioned herein above, in order to measure pressure at the distal region 202 (FIG. 10) of the medical device 100, an external pressure transducer may be coupled to the medical device 100. In the example of FIG. 8, an adapter 705 is operatively coupled to the external tubing 706, which is operatively coupled to an external pressure transducer 708. The adapter 705 is structured to couple to adapter 704 when in use. In some examples, adapters 704 and 705 comprise male and female Luer locks or other fluid connectors, adapted to readily couple and decouple to/from each other. In use, tubing 706 and 508 may be flushed with saline or another suitable fluid to remove air bubbles prior to measuring pressure. When medical device 100 is positioned in a vessel, conduit, or cavity of a body, fluid adjacent the distal region 202 (FIG. 10) exerts pressure through the side-port(s) 600 on fluid within the lumen 208, which in turn exerts pressure on fluid in tubing 508 and 706, which further exerts pressure on external pressure transducer 708. The side-port(s) 600 and the lumen 208 thus provide a pressure sensor in the form of a pressure transmitting lumen for coupling to a pressure transducer.

The external pressure transducer 708 produces a signal that varies as a function of the pressure it senses. The external pressure transducer 708 is electrically coupled to a pressure monitoring system 710 that is operative to convert the signal provided by the transducer 708 and display, for example, a pressure contour as a function of time. Thus, pressure is optionally measured and/or recorded and, in accordance with one embodiment of a method aspect as described further herein below, used to determine a position of the distal region 202. In those embodiments of the medical device 100 that do not comprise a lumen in fluid communication with the outside environment, a pressure transducer may be mounted at or proximate to the distal portion 112 of the medical device 100 and coupled to a pressure monitoring system, for example, via an electrical connection.

As previously mentioned, for some embodiments the medical device 100 is operatively coupled to a source of fluid 712 for delivering various fluids to the medical device 100 and thereby to a surrounding environment. The source of fluid 712 may be, for example, an IV bag or a syringe. The source of fluid 712 may be operatively coupled to the lumen 208 via the tubing 508 and the adapter 704, as mentioned herein above. Alternatively, or in addition, some embodiments include the medical device 100 being operatively coupled to an aspiration device for removing material from the patients body through one or more of the side-ports 600.

In one broad aspect, the medical apparatus is used in a method of establishing a conduit for fluid communication for a medical device 100, the medical device defining a device lumen 809 in fluid communication with a side-port 600. Making reference to FIGS. 4 to 9, the method comprises the steps of (a) inserting a medical device 100 having at least one side-port 600 into a tubular member 800, and (b) cooperatively defining a conduit 808 for fluid communication by positioning the side-port 600 of the medical device 100 at a location of the tubular member 800 where a space exists between the side-port 600 and a tubular member inner surface 804, the space extending at least between the side-port 600 and a distal end of the tubular member.

In some embodiments of the broad aspect, the medical device comprises a medical device proximal marker 810 proximal of the side-port, and a medical device distal marker 812 distal of the side-port, and step (b) includes visualizing at least one of the proximal marker and the distal marker to position the medical device. In some such embodiments, step (b) comprises positioning side-port 600 within tubular member lumen 802, for example, by using a medical device proximal marker 810 and a medical device distal marker 812. In such embodiments of the method, it is not necessary for distal tip 403 to be inside of tubular member lumen 802. In some embodiments of the method, the medical device further comprises a side-port marker wherein the side-port marker and the side-port are equidistant from a tip of the medical device, and wherein step (b) includes visualizing the side-port marker to position the medical device. In some other embodiments, step (b) comprises positioning distal portion 830 of distal portion 112 within tubular member lumen 802, which inherently positions the side-port in the tubular member lumen. In some embodiments of the method, step (b) includes aligning a distal tip 403 of the medical device with the tubular member distal end 801.

Some embodiments of the broad aspect further comprise a step (c) of delivering fluid through the side-port 600, wherein the fluid is a contrast fluid 814 and wherein step (c) includes delivering the contrast fluid distally through the distal end of the tubular member. Some such embodiments further comprise a step of delivering electrical energy to puncture tissue before the contrast fluid is delivered. Some embodiments comprise a step (d) of delivering electrical energy through the medical device to create a puncture through a tissue after the contrast fluid is delivered.

In some embodiments, the tissue comprises a septum of a heart, and step (c) comprises staining the septum by delivering contrast fluid through the side-port.

In some embodiments of the broad aspect, the side-port 600 and the device lumen 809 together comprise a pressure transmitting lumen, and the method further comprises a step (c) of measuring a pressure of an environment external to the distal end using the side-port and the conduit. Some such embodiments further comprise a step (d) of delivering fluid through the side-port.

Some embodiments of the broad aspect further comprise a step (c) of withdrawing fluid through the side-port 600. In some such embodiments, the fluid is blood.

In one example of a method of use, illustrated in FIGS. 9A and 9B, a target site comprises the atrial septum 822, a tissue within the heart of a patient. In this example, the target site is accessed via the inferior vena cava (IVC), for example, through the femoral vein. The medical device 100 of FIGS. 9A and 9B is similar to medical device of FIG. 4A, except the embodiment of FIG. 9 has a medical device proximal marker 810 and a medical device distal marker 812.

The example of the method includes a user advancing sheath 820 and a dilator (i.e. tubular member 800) through inferior vena cava 824, and introducing the sheath and tubular member 800 into the right atrium 826 of the heart. An electrosurgical device, for example medical device 100 described herein above, is then introduced into tubular member lumen 802, and advanced toward the heart. In typical embodiments of the method, these steps are performed with the aid of fluoroscopic imaging.

After inserting medical device 100 into tubular member 800, the user positions the distal end of tubular member 800 against the atrial septum 822 (FIG. 9A). Some embodiments of tubular member 800 include markers (FIG. 6A). The medical device is then positioned such that electrode 106 is aligned with or slightly proximal of the distal end of tubular member 800 (FIG. 9A insert). Medical device proximal marker 810 and medical device distal marker 812 facilitate positioning medical device 100. Tubular member 800 is typically positioned against the fossa ovalis of the atrial septum 822. Referring to the FIG. 9A insert, the inner surface of tubular member 800 and the outer surface of medical device 100 define conduit 808 from side-port 600 to the distal end of tubular member lumen 802, which is sealed by atrial septum 822.

Once medical device 100 and tubular member 800 have been positioned, additional steps can be performed, including taking a pressure measurement and/or delivering material to the target site, for example, a contrast agent, through side-port(s) 600. The FIG. 9A insert illustrates contrast fluid 814 flowing from side-port 600, through conduit 808, and ending at atrial septum 822, whereby the tissue is stained by the contrast fluid. In alternative examples, electrode 106 is positioned against atrial septum 822 when contrast fluid 814 is delivered. Such steps facilitate the localization of the electrode 106 at the desired target site.

Starting from the position illustrated by the FIG. 9A insert, medical device 100 is advanced until electrode 106 contacts atrial septum 822. (Alternative embodiments wherein electrode 106 is positioned against atrial septum 822 when contrast fluid 814 is delivered do not require this repositioning.) With the medical device 100 and the dilator (i.e. tubular member 800) positioned at the target site, energy is delivered from an energy source, through medical device 100, to the target site. The path of energy delivery is through elongate member 102 (or main member 210 and end member 212), to the electrode 106, and into the tissue at the target site. The example of FIG. 9A includes delivering energy to vaporize cells in the vicinity of the electrode, thereby creating a void or puncture through the tissue at the target site, and advancing distal portion 112 of the medical device 100 at least partially through the puncture. When the distal portion 112 has passed through the target tissue and reached the left atrium (FIG. 9B), energy delivery is stopped. The side-ports of medical device 100 are uncovered (FIG. 9B insert), whereby contrast may be delivered to confirm the position of distal portion 112 in the left atrium of the heart. The diameter of the puncture created by the delivery of energy is typically large enough to facilitate advancing distal portion 112 of the medical device 100 therethrough and to start advancing a dilator (i.e. tubular member 800).

Referring now to FIG. 10A, the elongate member 102 includes a proximal region 200, a distal region 202, a proximal end 204, and a distal end 206. In some embodiments of the invention, the elongate member 102 defines a lumen 208, which typically extends substantially between the proximal region 200 and the distal region 202.

The elongate member 102 is typically sized such that the handle 110 remains outside of the patient when the distal end 206 is within the body, for example, adjacent the target site. That is, the proximal end 204 is at a location outside of the body, while the distal end 206 is located within the heart of the patient. Thus, in some embodiments of the invention, the length of the elongate member 102, i.e., the sum of the force transmitting length and the distal portion length, is between about 30 cm and about 100 cm, depending, for example, on the specific application and/or target site.

The transverse cross-sectional shape of the elongate member 102 may take any suitable configuration, and the invention is not limited in this regard. For example, the transverse cross-sectional shape of the elongate member 102 is substantially circular, ovoid, oblong, or polygonal, among other possibilities. Furthermore, in some embodiments, the cross-sectional shape varies along the length of the elongate member 102. For example, in one embodiment, the cross-sectional shape of the proximal region 200 is substantially circular, while the cross-sectional shape of the distal region 202 is substantially ovoid.

In typical embodiments, the outer diameter of the elongate member 102 is sized such that it fits within vessels of the patient's body. For example, in some embodiments, the outer diameter of the elongate member 102 is between about 0.40 mm and about 1.5 mm (i.e. between about 27 Gauge and about 17 Gauge). In some embodiments, the outer diameter of the elongate member 102 varies along the length of the elongate member 102. For example, in some embodiments, the outer diameter of the elongate member 102 tapers from the proximal end 204 towards the distal end 206. In one specific embodiment, the outer diameter of the proximal region 200 of the elongate member 102 is about 1.5 mm. In this embodiment, at a point about 4 cm from the distal end 206, the outer diameter begins to decrease such that the distal end 206 of the elongate member 102 is about 0.7 mm in outer diameter. In a further embodiment, the outer diameter of the elongate member 102 tapers from about 1.3 mm to about 0.8 mm at a distance of about 1.5 mm from the distal end 206. FIG. 10B is an example of a taper in elongate member 102 occurring smoothly, for example, over a length of about 4 cm. FIG. 10C is an example of a taper occurring more abruptly, for example, over a length of about 1 mm or less. The taper may be applied to the elongate member 102 by a variety of methods. In some embodiments, the elongate member 102 is manufactured with the taper already incorporated therein. In other embodiments, the elongate member 102 is manufactured without a taper, and the taper is created by swaging the elongate member down to the required outside diameter, or by machining the distal region 202 such that the outside diameter tapers while the inside diameter remains constant.

In a further embodiment, the elongate member 102 is manufactured from two pieces of material, each having a different diameter, which are joined together. For example, as shown in FIG. 10D, the elongate member 102 includes a main member 210 mechanically coupled to the handle (not shown in FIG. 10D), the main member 210 having a length of about 50 cm to about 100 cm and an outer diameter of about 1.15 mm to about 1.35 mm. The main member 210 defines a main member lumen 214, as shown in FIG. 2E, extending substantially longitudinally therethrough. The main member is co-axially joined to an end member 212, having a length of about 2.5 cm to about 10 cm and an outer diameter of about 0.40 mm to about 0.80 mm. In some examples, the end member 212 is inserted partially into the main member lumen 214, substantially longitudinally opposed to the handle 110. In some embodiments, the electrode 106 is located about the end member, for example, by being mechanically coupled to the end member 212, while in other embodiments the electrode 106 is integral with the end member 212. If the end member 212 defines an end member lumen 216, as seen in FIGS. 10D and 2E, the end member lumen 216 is in fluid communication with the main member lumen 214, as shown in FIG. 2E. The main member 210 and the end member 212 are joined in any suitable manner, for example welding, soldering, friction fitting, or the use of adhesives, among other possibilities. Also, in some embodiments, the main member lumen 214 and the end member lumen 216 have substantially similar diameters, which reduces turbulence in fluids flowing through the main member lumen 214 and the end member lumen 216.

In embodiments of the invention wherein the elongate member 102 defines a lumen 208, the wall thickness of the elongate member 102 may vary depending on the application, and the invention is not limited in this regard. For example, if a stiffer device is desirable, the wall thickness is typically greater than if more flexibility is desired. In some embodiments, the wall thickness in the force transmitting region is from about 0.05 mm to about 0.40 mm, and remains constant along the length of the elongate member 102. In other embodiments, wherein the elongate member 102 is tapered, the wall thickness of the elongate member 102 varies along the elongate member 102. For example, in some embodiments, the wall thickness in the proximal region 200 is from about 0.1 mm to about 0.4 mm, tapering to a thickness of from about 0.05 mm to about 0.20 mm in the distal region 202. In some embodiments, the wall tapers from inside to outside, thereby maintaining a consistent outer diameter and having a changing inner diameter. Alternative embodiments include the wall tapering from outside to inside, thereby maintaining a consistent inner diameter and having a changing outer diameter. Further alternative embodiments include the wall of the elongate member 102 tapering from both the inside and the outside, for example, by having both diameters decrease such that the wall thickness remains constant. For example, in some embodiments the lumen 208 has a diameter of from about 0.4 mm to about 0.8 mm at the proximal region 200, and tapers to a diameter of from about 0.3 mm to about 0.5 mm at the distal region 202. In other alternative embodiments, the outer diameter decreases while the inner diameter increases, such that the wall tapers from both the inside and the outside.

In some embodiments, the elongate member 102, and therefore the medical device 100, are curved or bent, as shown in FIGS. 11A-11C. As used herein, the terms ‘curved’ or bent refer to any region of non-linearity, or any deviation from a longitudinal axis of the device, regardless of the angle or length of the curve or bend. The medical device 100 includes a substantially rectilinear section 302 and a curved section 300 extending from the substantially rectilinear section 302. Typically, the curved section 300 is located in the distal region 202 of the elongate member 102, and may occur over various lengths and at various angles. In some examples, curved section 300 has a relatively large radius, for example, between about 10 cm and about 25 cm, and traverses a small portion of a circumference of a circle, for example between about 20 and about 40 degrees, as shown in FIG. 11B. In alternative examples, the curved section 300 has a relatively small radius, for example, between about 4 cm and about 7 cm, and traverses a substantially large portion of a circumference of a circle, for example, between about 50 and about 110 degrees, as shown in FIG. 11C. In one specific embodiment, the curved section 300 begins about 8.5 cm from the distal end 206 of the elongate member 102, has a radius of about 6 cm, and traverses about 80 degrees of a circumference of a circle. In an alternative embodiment, the curved section has a radius of about 5.4 cm and traverses about 50 degrees of a circumference of a circle. In a further embodiment, the curved section has a radius of about 5.7 cm and traverses about 86 degrees of a circumference of a circle. This configuration helps in positioning the elongate member 102 such that the distal end 206 is substantially perpendicular to the tissue through which the channel is to be created. This perpendicular positioning transmits the most energy when a user exerts a force through the elongate member 102, which provides enhanced feedback to the user.

The curved section 300 may be applied to the elongate member 102 by a variety of methods. For example, in one embodiment, the elongate member 102 is manufactured in a curved mold. In another embodiment, the elongate member 102 is manufactured in a substantially straight shape then placed in a heated mold to force the elongate member 102 to adopt a curved shape. Alternatively, the elongate member 102 is manufactured in a substantially straight shape and is forcibly bent by gripping the elongate member 102 just proximal to the region to be curved and applying force to curve the distal region 202. In an alternative embodiment, the elongate member 102 includes a main member 210 and an end member 212, as described with respect to FIG. 10D, which are joined together at an angle (not shown in the drawings). That is, rather than being coaxial, the main member 210 and an end member 212 are joined such that, for example, they are at an angle of 45° with respect to each other.

As mentioned herein above, in some embodiments the proximal region 200 of the elongate member 102 is structured to be coupled to an energy source. To facilitate this coupling, the proximal region 200 may comprise a hub 108 that allows for the energy source to be electrically connected to the elongate member 102. Further details regarding the hub 108 are described herein below. In other embodiments, the proximal region 200 is coupled to an energy source by other methods known to those of skill in the art, and the invention is not limited in this regard.

In typical embodiments, the elongate member 102 is made from an electrically conductive material that is biocompatible. As used herein, ‘biocompatible’ refers to a material that is suitable for use within the body during the course of a surgical procedure. Such materials include stainless steels, copper, titanium and nickel-titanium alloys (for example, NITINOL®), amongst others. Furthermore, in some embodiments, different regions of the elongate member 102 are made from different materials. In an example of the embodiment of FIG. 10D, the main member 210 is made from stainless steel such that it provides column strength to a portion of the elongate member 102 (for example, the force transmitting portion), and the end member 212 is made out of a nickel-titanium alloy such as NITINOL®, such that it provides flexibility to a portion of the elongate member 102 (for example, the distal portion). Embodiments wherein the force transmitting portion of the elongate member 102 is manufactured from stainless steel often result in medical device 100 having a similar amount of column strength to a device of the prior art, for example, a mechanical perforator such as a Brockenbrough™ needle. This is beneficial in that it provides a familiar ‘feel’ to users familiar with such devices. In some embodiments comprising a curved or bent elongate member 102, the rectilinear section 302 is made from stainless steel such that it provides column strength to the elongate member 102, and the curved section 300 is made out of a nickel-titanium alloy such as NITINOL®, such that it provides flexibility to the elongate member 102. In addition, the use of NITINOL® for curved section 300 is advantageous as the superelastic properties of this material helps in restoring the shape of the curved section 300 after the curved section 300 is straightened out, for example, when placed within a dilator.

As mentioned herein above, an electrical insulation 104 is disposed on at least a portion of the outer surface of the elongate member 102. In some embodiments, for example as shown in FIG. 1, electrical insulation 104 covers the circumference of the elongate member 102 from the proximal region 200 of the elongate member 102 to the distal region 202 of the elongate member 102. In other words, the force transmitting portion 114 and distal portion 112 are electrically conductive, and the electrical insulation substantially covers the force transmitting portion 114 and distal portion 112, while the electrode 106 remains substantially uninsulated. When a source of energy is coupled to the proximal region 200 of the elongate member 102, the electrical insulation 104 substantially prevents leakage of energy along the length of the elongate member 102, thus allowing energy to be delivered from the proximal region 200 of the elongate member 102 to the electrode 106.

In embodiments as illustrated in FIG. 1, the electrical insulation 104 may extend to different locations on the distal region 202 (FIG. 10), depending on the configuration of the electrode 106. Typically, electrical insulation 104 extends to a proximal end 404 of the electrode 106, which may or may not coincide with the distal end of the elongate member 102. For example, as shown in FIG. 3A, the distal-most 1.5 mm of the elongate member 102 serves as at least a portion of the electrode 106. In these embodiments, electrical insulation 104 extends to a point about 1.5 mm proximal to the distal end 206 of the elongate member 102. In the embodiments of FIGS. 3B-3C, an external component 400 coupled to the distal end of the elongate member 102 serves as the electrode 106. In such embodiments, the proximal end 404 of the electrode 106 substantially coincides with the distal end 206 of the elongate member 102, and thus the electrical insulation 104 extends to the distal end 206 of the elongate member 102. In some embodiments, the electrical insulation 104 extends beyond the distal end 206 of the elongate member 102, and covers a portion of the external component 400. This typically aids in securing the external component 400 to the elongate member 102. The uncovered portion of the external component 400 can then serve as the electrode 106. In other embodiments, for example as shown in FIG. 3A, the distal-most portion of the elongate member 102, as well as a rounded external component 402, serve as the electrode 106. In this embodiment, the electrical insulation 104 extends to a point substantially adjacent to the distal end 206 of the elongate member 102. In one example, the electrical insulation 104 extends to a point about 1.0 mm away from the distal end 206 of the elongate member 102.

The electrical insulation 104 may be one of many biocompatible dielectric materials, including but not limited to, polytetrafluoroethylene (PTFE, Teflon®), parylene, polyimides, polyethylene terepthalate (PET), polyether block amide (PEBAX®), and polyetheretherketone (PEEK™), as well as combinations thereof. The thickness of the electrical insulation 104 may vary depending on the material used. Typically, the thickness of the electrical insulation 104 is from about 0.02 mm to about 0.12 mm.

In some embodiments, the electrical insulation 104 comprises a plurality of dielectric materials. This is useful, for example, in cases where different properties are required for different portions of the electrical insulation 104. In certain applications, for example, substantial heat is generated at the electrode 106. In such applications, a material with a sufficiently high melting point is required for the distal-most portion of the electrical insulation 104, so that this portion of the electrical insulation 104, located adjacent to electrode 106, doesn't melt. Furthermore, in some embodiments, a material with a high dielectric strength is desired for all of, or a portion of, the electrical insulation 104. In some particular embodiments, electrical insulation 104 has a combination of both of the aforementioned features.

With reference now to FIG. 2E, the electrical insulation 104 includes a first electrically insulating layer 218 made out of a first electrically insulating material, and a second electrically insulating layer 220 made out of a second electrically insulating material, and being substantially thinner than the first electrically insulating layer 218. The first electrically insulating layer 218 substantially covers the main member 210 substantially adjacent the end member 212, and the second electrically insulating layer 220 substantially covers the end member 212, with the electrode 106 substantially deprived from the second electrically insulating layer 220. In the illustrated embodiment, the first electrically insulating layer 218 overlaps the second electrically insulating layer 220 about the region of the taper of the elongate member 102. This configuration provides desirable mechanical properties for the medical device 100, as thinner materials are typically less rigid than thicker materials. Also, in some embodiments of the invention, the first electrically insulating layer 218 overlaps a portion of the second electrically insulating layer 220. However, in alternative embodiments of the invention, the electrical insulation 104 has any other suitable configuration, for example, the first electrically insulating layer 218 and the second electrically insulating layer 220 being made of the same material.

In further embodiments as shown in FIG. 3D, a heat shield 109 may be applied to the medical device 100 substantially adjacent to the electrode 106, for example, in order to prevent a distal portion of the electrical insulation 104 from melting due to heat generated by the electrode 106. For example, in some such embodiments, a thermally insulating material, for example Zirconium Oxide or polytetrafluoroethylene (PTFE), is applied over approximately the distal-most 2 cm of the electrical insulation 104. Typically, the heat shield 109 protrudes substantially radially outwardly from the remainder of the distal portion 112 and substantially longitudinally from the electrode 106 in a direction leading towards the handle 110.

The electrical insulation 104 may be applied to the elongate member 102 by a variety of methods. For example, if the electrical insulation 104 includes PTFE, it may be provided in the form of heat-shrink tubing, which is placed over the elongate member 102 and subjected to heat to substantially tighten around the elongate member 102. If the electrically insulating material is parylene, for example, it may be applied to the elongate member 102 by vapor deposition. In other embodiments, depending on the specific material used, the electrical insulation 104 may be applied to the elongate member 102 using alternate methods such as dip-coating, co-extrusion, or spraying.

As mentioned herein above, in embodiments of the present invention the elongate member 102 comprises an electrode 106 at the distal region, the electrode 106 configured to create a channel via radiofrequency perforation. As used herein, ‘radiofrequency perforation’ refers to a procedure in which radiofrequency (RF) electrical energy is applied from a device to a tissue to create a perforation or fenestration through the tissue. Without being limited to a particular theory of operation, it is believed that the RF energy serves to rapidly increase tissue temperature to the extent that water in the intracellular fluid converts to steam, inducing cell lysis as a result of elevated pressure within the cell. Furthermore, electrical breakdown may occur within the cell, wherein the electric field induced by the alternating current exceeds the dielectric strength of the medium located between the radiofrequency perforator and the cell, causing a dielectric breakdown. In addition, mechanical breakdown may occur, wherein alternating current induces stresses on polar molecules in the cell. Upon the occurrence of cell lysis and rupture, a void is created, allowing the device to advance into the tissue with little resistance. In order to increase the current density delivered to the tissue and achieve this effect, the device from which energy is applied, i.e. the electrode, is relatively small, having an electrically exposed surface area of no greater than about 15 mm². In addition, the energy source is capable of applying a high voltage through a high impedance load, as will be discussed further herein below. This is in contrast to RF ablation, whereby a larger-tipped device is utilized to deliver RF energy to a larger region in order to slowly desiccate the tissue. As opposed to RF perforation, which creates a void in the tissue through which the device is advanced, the objective of RF ablation is to create a large, non-penetrating lesion in the tissue, in order to disrupt electrical conduction. Thus, for the purposes of the present invention, the electrode refers to a device which is electrically conductive and exposed, having an exposed surface area of no greater than about 15 mm², and which is operable to delivery energy to create a perforation or fenestration through tissue when coupled to a suitable energy source and positioned at a target site. The perforation is created, for example, by vaporizing intracellular fluid of cells with which it is in contact, such that a void, hole, or channel is created in the tissue located at the target site.

In further embodiments, as shown in FIG. 3A, it is desirable for the distal end 206 of the elongate member 102 to be closed. For example, in some embodiments, it is desirable for fluids to be injected radially from the elongate member 102, for example, through side-ports in elongate member 102 substantially without being injected distally from the elongate member 102, as discussed herein below. In these embodiments, a closed distal end 206 facilitates radial injection of fluid while preventing distal injection.

It is a common belief that it is necessary to have a distal opening in order to properly deliver a contrast agent to a target site. However, it was unpredictably found that it is possible to properly operate the medical device 100 in the absence of distal openings. Advantageously, these embodiments reduce the risk that a core of tissue becomes stuck in such a distal opening when creating the channel through the tissue. Avoiding such tissue cores is desirable as they may enter the blood circulation, which creates risks of blocking blood vessels, leading to potentially lethal infarctions.

Thus, as shown in FIG. 3A, a rounded external component 402, for example an electrode tip, is operatively coupled to the distal end 206. In this embodiment, the exposed portion of the distal region 202 (FIG. 10A to 10D), as well as the rounded external component 402, serves as the electrode 106. In such an embodiment, if the outer diameter of the elongate member 102 is 0.7 mm, the rounded external component 402 is a hemisphere having a radius of about 0.35 mm, and the length of the distal-most exposed portion of the elongate member 102 is about 2.0 mm, and then the surface area of the electrode 106 is about 5.2 mm². Alternatively, as shown for example in FIG. 2E, the distal end of end member 212 is closed and used as the electrode 106, rather than a separate external component.

In other embodiments as shown, for example, in FIGS. 3B and 3C, an electrically conductive and exposed external component 400 is electrically coupled to the distal end of the elongate member 102, such that the external component 400 serves as the electrode 106. In such embodiments, external component 400 is a cylinder having a diameter of between about 0.4 mm and about 1 mm, and a length of about 2 mm. Electrode 106 thus has an exposed surface area of between about 2.6 mm²and about 7.1 mm².

The external component 400 may take a variety of shapes, for example, cylindrical, main, conical, or truncated conical. The distal end of the external component 400 may also have different configuration, for example, rounded, or flat. Furthermore, some embodiments of the external component 400 are made from biocompatible electrically conductive materials, for example, stainless steel. The external component 400 may be coupled to the elongate member 102 by a variety of methods. In one embodiment, external component 400 is welded to the elongate member 102. In another embodiment, external component 400 is soldered to the elongate member 102. In one such embodiment, the solder material itself comprises the external component 400, e.g., an amount of solder is electrically coupled to the elongate member 102 in order to function as at least a portion of the electrode 106. In further embodiments, other methods of coupling the external component 400 to the elongate member 102 are used, and the invention is not limited in this regard.

In these embodiments, as described herein above, the electrically exposed and conductive surface area of the electrode 106 is no greater than about 15 mm². In embodiments wherein the electrical insulation 104 covers a portion of the external component 400, the portion of the external component 400 that is covered by the electrical insulation 104 is not included when determining the surface area of the electrode 106.

Referring again to FIG. 3A, in some embodiments, the distal portion 112 defines a distal tip 403, the distal tip 403 being substantially atraumatic. In other words, the distal end of the medical device 100 is structured such that it is substantially atraumatic, or blunt. As used herein, the terms ‘atraumatic’ and ‘blunt’ refer to a structure that is not sharp, and includes structures that are rounded, obtuse, or flat, amongst others, as shown, for example, in FIG. 3A. In embodiments wherein the distal end of the medical device 100 is substantially blunt, the blunt distal end is beneficial for avoiding unwanted damage to non-target areas within the body. That is, if mechanical force is unintentionally applied to the medical device 100 when the distal end of the medical device 100 is located at a non-target tissue, the medical device 100 is less likely to perforate the non-target tissue.

In some embodiments, the distal tip 403 is substantially bullet-shaped, as shown in FIG. 2E, which allows the intended user to drag the distal tip 403 across the surface of tissues in the patient's body and to catch on to tissues at the target site. For example, if the target site includes a fossa ovalis, as described further herein below, the bullet-shaped tip may catch on to the fossa ovalis so that longitudinal force applied at a proximal portion of medical device 100 causes the electrode 106 to advance into and through the fossa ovalis rather than slipping out of the fossa ovalis. Because of the tactile feedback provided by the medical device 100, this operation facilitates positioning of the medical device 100 prior to energy delivery to create a channel.

As mentioned herein above, in some embodiments, the medical device 100 comprises a hub 108 coupled to the proximal region. In some embodiments, the hub 108 is part of the handle 110 of the medical device 100, and facilitates the connection of the elongate member 102 to an energy source and a fluid source, for example, a contrast fluid source.

In the embodiment illustrated in FIGS. 12A and 12B, the proximal region 200 the of the elongate member 102 is electrically coupled to the hub 108, which is structured to electrically couple the elongate member 102 to a source of energy, for example, a radiofrequency generator. In one embodiment, the hub 108 comprises a conductive wire 500 that is connected at one end to the elongate member 102, for example, by welding or brazing. The other end of the wire 500 is coupled to a connector (i.e. a connector means for receiving), for example a banana jack 502, that can be electrically coupled to a banana plug 504, which is electrically coupled to a source of energy. Thus, electrical energy may be delivered from the energy source, through plug 504, jack 502, and wire 500 to the elongate member 102 and electrode 106. In other embodiments, other hubs or connectors that allow elongate member 102 to be connected to a source of fluid and a source of energy are used, and the invention is not limited in this regard.

In some embodiments, medical device 100 is a transseptal puncturing device comprising an elongate member which is electrically conductive, an electrical connector in electrical communication with the elongate member, and an electrode at a distal end of the electrically conductive elongate member for delivering energy to tissue. A method of using the transseptal puncturing device comprises the steps of (1) connecting an electrically conductive component, which is in electrical communication with a source of energy, to the electrical connector, and (2) delivering electrical energy through the electrode to a tissue. The electrically conductive component may comprise a plug, such as plug 504, and a wire connected thereto. Some embodiments of the method further comprise a step (3) of disconnecting the electrically conductive component from the electrical connector. In such embodiments, the electrically conductive component is connected in a releasable manner.

In some embodiments, the hub 108 is structured to be operatively coupled to a fluid connector 506, for example a Luer lock, which is connected to tubing 508. Tubing 508 is structured to be operatively coupled at one end to an aspirating device, a source of fluid 712 (for example a syringe), or a pressure sensing device (for example a pressure transducer 708). The other end of tubing 508 may be operatively coupled to the fluid connector 506, such that tubing 508 and lumen 208 are in fluid communication with each other, thus allowing for a flow of fluid between an external device and the lumen 208. In embodiments in which a hub 108 is part of handle 110, fluid and/or electrical connections do not have to be made only with the hub 108 i.e. connections may be made with other parts of the handle 110, or with parts of medical device 100 other than the handle.

In some embodiments, the hub 108 further comprises one or more curve-direction or orientation indicators 510 that are located on one side of the hub 108 to indicate the direction of the curved section 300. The orientation indicator(s) 510 may comprise inks, etching, or other materials that enhance visualization or tactile sensation.

In some embodiments of the invention, the handle 110 includes a relatively large, graspable surface so that tactile feedback can be transmitted relatively efficiently, for example by transmitting vibrations. In some embodiments of the invention, the handle 110 includes ridges 512, for example, in the hub 108, which enhance this tactile feedback. The ridges 512 allow the intended user to fully grasp the handle 110 without holding the handle 110 tightly, which facilitates the transmission of this feedback.

In some embodiments of the invention, the medical device 100, as shown in FIG. 2E, defines a lumen peripheral surface 602 extending substantially peripherally relative to the end member lumen 216, the lumen peripheral surface 602 being substantially covered with a lumen electrically insulating material 604. This configuration prevents or reduces electrical losses from the lumen peripheral surface 602 to any electrically conductive fluid located within the lumen 208. However, in other embodiments of the invention, the lumen peripheral surface 602 is not substantially covered with the lumen electrically insulating material 604.

Also, in some embodiments of the invention that include the curved section 300, the curved section 300 defines a center of curvature (not shown in the drawings), and the side-port(s) 600 extend from the lumen 208 substantially towards the center of curvature. This configuration substantially prevents the edges of the side-port(s) 600 from catching onto tissues as the tissues are perforated. However, in alternative embodiments of the invention, the side-port(s) 600 extend in any other suitable orientation.

In some embodiments, one or more radiopaque markers 714 (as shown in FIG. 8) are associated with the medical device 100 to highlight the location of important landmarks on medical device 100. Such landmarks include the location where the elongate member 102 begins to taper, the location of the electrode 106, or the location of any side-port(s) 600. In some embodiments, the entire distal region 202 of the medical device 100 is radiopaque. This can be achieved by filling the electrical insulation 104, for example Pebax®, with a radiopaque filler, for example Bismuth.

In some embodiments, the shape of the medical device 100 may be modifiable. For example, in some applications, it is desired that medical device 100 be capable of changing between a straight configuration, for example as shown in FIG. 1, and a curved configuration, for example as shown in FIGS. 11A-11C. This may be accomplished by coupling a pull-wire to the medical device 100, such that the distal end of the pull-wire is operatively coupled to the distal region of the medical device 100. When a user applies force to the proximal end of the pull wire, either directly or through an actuating mechanism, the distal region 202 of the medical device 100 is forced to deflect in a particular direction. In other embodiments, other means for modifying the shape of the medical device 100 are used, and the invention is not limited in this regard.

In some embodiments, the medical device 100 includes at least one further electrically conductive component, located proximal to the electrode 106. For example, the electrically conductive component may be a metal ring positioned on or around the electrical insulation 104 which has a sufficiently large surface area to be operable as a return electrode. In such an embodiment, the medical device 100 may function in a bipolar manner, whereby electrical energy flows from the electrode 106, through tissue at the target site, to the at least one further electrically conductive component. Furthermore, in such embodiments, the medical device 100 includes at least one electrical conductor, for example a wire, for conducting electrical energy from the at least one further conductive component to a current sink, for example, circuit ground.

In some embodiments, medical device 100 is used in conjunction with a source of radiofrequency energy suitable for perforating material within a patient's body. The source of energy may be a radiofrequency (RF) electrical generator 700, operable in the range of about 100 kHz to about 1000 kHz, and designed to generate a high voltage over a short period of time. More specifically, in some embodiments, the voltage generated by the generator increases from about 0 V (peak-to-peak) to greater than about 75 V (peak-to-peak) in less than about 0.6 seconds. The maximum voltage generated by generator 700 may be between about 180V peak-to-peak and about 3000V peak-to-peak. The waveform generated may vary, and may include, for example, a sine-wave, a rectangular-wave, or a pulsed rectangular wave, amongst others. During delivery of radiofrequency energy, the impedance load may increase due to occurrences such as tissue lesioning near the target-site, or the formation of a vapor layer following cell rupture. In some embodiments, the generator 700 is operable to continue to increase the voltage, even as the impedance load increases. For example, energy may be delivered to a tissue within a body at a voltage that rapidly increases from about 0 V (RMS) to about 220 V (RMS) for a period of between about 0.5 seconds and about 5 seconds.

Without being limited to a particular theory of operation, it is believed that under particular circumstances, as mentioned herein above, dielectric breakdown and arcing occur upon the delivery of radiofrequency energy, whereby polar molecules are pulled apart. The combination of these factors may result in the creation of an insulative vapor layer around the electrode, therein resulting in an increase in impedance, for example, the impedance may increase to greater than 4000Ω. In some embodiments, despite this high impedance, the voltage continues to increase. Further increasing the voltage increases the intensity of fulguration, which may be desirable as it allows for an increased perforation rate. An example of an appropriate generator for this application is the BMC RF Perforation Generator (model number RFP-100, Baylis Medical Company, Montreal, Canada). This generator delivers continuous RF energy at about 460 kHz.

In some embodiments, a dispersive electrode or grounding pad 702 is electrically coupled to the generator 700 for contacting or attaching to a patient's body to provide a return path for the RF energy when the generator 700 is operated in a monopolar mode. Alternatively, in embodiments utilizing a bipolar device, as described hereinabove, a grounding pad is not necessary as a return path for the RF energy is provided by the further conductive component.

In the embodiment illustrated in FIGS. 12A and 12B, the medical device 100 is operatively coupled to the tubing 508 using fluid connector 506 located at the proximal end of the medical device 100. In some embodiments, the tubing 508 is made of a polymeric material such as polyvinylchloride (PVC), or another flexible polymer. Some embodiments include the tubing 508 being operatively coupled to an adapter 704. The adapter is structured to provide a flexible region for the user to handle when releasably coupling an external pressure transducer, a fluid source, or other devices to the adapter. In some embodiments, couplings between elongate member 102, fluid connector 506, and tubing 508, and between tubing 508 and adapter 704, are temporary couplings such as Luer locks or other releasable components. In alternative embodiments, the couplings are substantially permanent, for example a bonding agent such as a UV curable adhesive, an epoxy, or another type of bonding agent. Some embodiments of the medical device 100 include a distal aperture in fluid communication with the lumen 208 wherein the distal aperture is a side-port 600, while some alternative embodiments have a distal aperture defined by an open distal end.

In one broad aspect, the electrosurgical medical device 100 is usable to deliver energy to a target site within a patient's body to perforate or create a void or channel in a material at the target site. Further details regarding delivery of energy to a target site within the body may be found in U.S. patent application Ser. No. 13/113,326 (filed on May 23, 2011), Ser. No. 10/347,366 (filed on Jan. 21, 2003, now U.S. Pat. No. 7,112,197), Ser. No. 10/760,749 (filed on Jan. 21, 2004), Ser. No. 10/666,288 (filed on Sep. 19, 2003), and Ser. No. 11/265,304 (filed on Nov. 3, 2005), and U.S. Pat. No. 7,048,733 (application Ser. No. 10/666,301, filed on Sep. 19, 2003) and U.S. Pat. No. 6,565,562 (issued on May 20, 2003), all of which are incorporated herein by reference.

In one specific embodiment, the target site comprises a tissue within the heart of a patient, for example, the atrial septum of the heart. In such an embodiment, the target site may be accessed via the inferior vena cava (IVC), for example, through the femoral vein.

In one such embodiment, an intended user introduces a guidewire into a femoral vein, typically the right femoral vein, and advances it towards the heart. A guiding sheath, for example, a sheath as described in U.S. patent application Ser. No. 10/666,288 (filed on Sep. 19, 2003), previously incorporated herein by reference, is then introduced into the femoral vein over the guidewire, and advanced towards the heart. The distal ends of the guidewire and sheath are then positioned in the superior vena cava. These steps may be performed with the aid of fluoroscopic imaging. When the sheath is in position, a dilator, for example the TorFlex™ Transseptal Dilator of Baylis Medical Company Inc. (Montreal, Canada), or the dilator as described in U.S. patent application Ser. No. 11/727,382 (filed on Mar. 26, 2007), incorporated herein by reference, is introduced into the sheath and over the guidewire, and advanced through the sheath into the superior vena cava. The sheath aids in preventing the dilator from damaging or puncturing vessel walls, for example, in embodiments comprising a substantially stiff dilator. Alternatively, the dilator may be fully inserted into the sheath prior to entering the body, and both may be advanced simultaneously towards the heart. When the guidewire, sheath, and dilator have been positioned in the superior vena cava, the guidewire is removed from the body, and the sheath and dilator are retracted slightly such that they enter the right atrium of the heart. An electrosurgical device, for example medical device 100 described herein above, is then introduced into the lumen of the dilator, and advanced toward the heart.

In this embodiment, after inserting the electrosurgical device into the dilator, the user positions the distal end of the dilator against the atrial septum. The electrosurgical device is then positioned such that electrode 106 is aligned with or protruding slightly from the distal end of the dilator. When the electrosurgical device and the dilator have been properly positioned, for example, against the fossa ovalis of the atrial septum, a variety of additional steps may be performed. These steps may include measuring one or more properties of the target site, for example, an electrogram or ECG (electrocardiogram) tracing and/or a pressure measurement, or delivering material to the target site, for example, delivering a contrast agent through side-port(s) 600 and/or open distal end 206. Such steps may facilitate the localization of the electrode 106 at the desired target site. In addition, as mentioned herein above, the tactile feedback provided by the proposed medical device 100 is usable to facilitate positioning of the electrode 106 at the desired target site.

With the electrosurgical device and the dilator positioned at the target site, energy is delivered from the energy source, through medical device 100, to the target site. For example, energy is delivered through the elongate member 102, to the electrode 106, and into the tissue at the target site. In some embodiments, the energy is delivered at a power of at least about 5 W at a voltage of at least about 75 V (peak-to-peak), and, as described herein above, functions to vaporize cells in the vicinity of the electrode, thereby creating a void or perforation through the tissue at the target site. If the heart was approached via the inferior vena cava, as described herein above, the user applies force in the substantially cranial direction to the handle 110 of the electrosurgical device as energy is being delivered. The force is then transmitted from the handle to the distal portion 112 of the medical device 100, such that the distal portion 112 advances at least partially through the perforation. In these embodiments, when the distal portion 112 has passed through the target tissue, that is, when it has reached the left atrium, energy delivery is stopped. In some embodiments, the step of delivering energy occurs over a period of between about 1 s and about 5 s.

At this point in the procedure, the diameter of the perforation is typically substantially similar to the outer diameter of the distal portion 112. In some examples, the user may wish to enlarge the perforation, such that other devices such as ablation catheters or other surgical devices are able to pass through the perforation. Typically, to do this, the user applies force to the proximal region of the dilator, for example, in the cranial direction if the heart was approached via the inferior vena cava. The force typically causes the distal end of the dilator to enter the perforation and pass through the atrial septum. The electrosurgical device is operable to aid in guiding the dilator through the perforation, by acting as a substantially stiff rail for the dilator. In such embodiments, a curve, for example, curved section 300 of the medical device 100, typically assists in anchoring the electrosurgical device in the left atrium. In typical embodiments, as force is applied, portions of the dilator of larger diameter pass through the perforation, thereby dilating, expanding, or enlarging the perforation. In some embodiments, the user also applies torque to aid in maneuvering the dilator. Alternatively, in embodiments wherein the device is tapered, the device may be advanced further into the left atrium, such that larger portions of the device enter and dilate the perforation.

In some embodiments, when the perforation has been dilated to a suitable size, the user stops advancing the dilator. A guiding sheath is then advanced over the dilator through the perforation. In alternative embodiments, the sheath is advanced simultaneously with the dilator. At this point in the procedure, the user may retract the dilator and the electrosurgical device proximally through the sheath, leaving only the sheath in place in the heart. The user is then able to perform a surgical procedure on the left side of the heart via the sheath, for example, introducing a surgical device into the femoral vein through the sheath for performing a surgical procedure to treat electrical or morphological abnormalities within the left side of the heart.

If an apparatus of the present invention, as described herein above, is used to carry out a procedure as described herein, then the user is able to maintain the ‘feel’ of a mechanical perforator, for example a Brockenbrough™ needle, without requiring a sharp tip and large amounts of mechanical force to perforate the atrial septum. Rather, a radiofrequency perforator, for example, the electrode 106, is used to create a void or channel through the atrial septum, as described herein above, while reducing the risk of accidental puncture of non-target tissues.

In other embodiments, methods of the present invention may be used for treatment procedures involving other regions within the body, and the invention is not limited in this regard. For example, rather than the atrial septum, embodiments of devices, systems, and methods of the present invention can be used to treat pulmonary atresia. In some such embodiments, a sheath is introduced into the vascular system of a patient and guided to the heart, as described herein above. A dilator is then introduced into the sheath, and advanced towards the heart, where it is positioned against the pulmonary valve. An electrosurgical device comprising an electrode is then introduced into the proximal region of the dilator, and advanced such that it is also positioned against the pulmonary valve. Energy is then delivered from the energy source, through the electrode of the electrosurgical device, to the pulmonary valve, such that a puncture or void is created as described herein above. When the electrosurgical device has passed through the valve, the user is able to apply a force to the proximal region of the dilator, for example, in a substantially cranial direction. The force can be transmitted to the distal region of the dilator such that the distal region of the dilator enters the puncture and advances through the pulmonary valve. As regions of the dilator of larger diameter pass through the puncture, the puncture or channel becomes dilated.

In other applications, embodiments of a device of the present invention can be used to create voids or channels within or through other tissues of the body, for example within or through the myocardium of the heart. In other embodiments, the device is used to create a channel through a fully or partially occluded lumen within the body. Examples of such lumens include, but are not limited to, blood vessels, the bile duct, airways of the respiratory tract, and vessels and/or tubes of the digestive system, the urinary tract and/or the reproductive system. In such embodiments, the device is typically positioned such that an electrode of the device is substantially adjacent the material to be perforated. Energy is then delivered from an energy source, through the electrode 106, to the target site such that a void, puncture, or channel is created in or through the tissue.

This disclosure describes embodiments of a kit and its constituent components which together form an apparatus in which fluid communication between a medical device's lumen and the surrounding environment is provided by a conduit cooperatively defined by the medical device and a tubular member into which the device is inserted. The medical device and tubular member are configured to fit together such that an outer surface of the distal region of the medical device cooperates with an inner surface of the tubular member to define the conduit between the side-port of the medical device and a distal end of the tubular member. The conduit is operable for a variety of applications including injecting fluid, withdrawing fluid, and measuring pressure. Methods of assembling and using the apparatus are described as well.

This disclosure further describes an electrosurgical device configured for force transmission from a distal portion of the electrosurgical device to a proximal portion of the electrosurgical device to thereby provide tactile feedback to a user. The proximal portion of the device comprises a handle and/or a hub, with the handle (or hub) including an electrical connector (i.e. a connector means) which is configured to receive, in a releasable manner, an electrically conductive component which is operable to be in electrical communication with an energy source to allow the user to puncture a tissue layer. In some cases, a radiofrequency (RF) energy source is used to selectively apply RF energy to the tissue. Typical embodiments of the device include insulation to protect the user and the patient.

The embodiments of the invention described above are intended to be exemplary only. The scope of the invention is therefore intended to be limited solely by the scope of the appended claims.

It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable sub-combination.

Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations are apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications, and variations that fall within the scope of the appended claims.

Claims

1. An electrosurgical device comprising an electrically conductive elongate member which is a metal tube and defining a proximal portion and a distal portion having an integral puncturing distal end, the metal tube being capable of force transmission from the distal portion to the proximal portion to thereby provide tactile feedback to a user, the proximal portion comprising a handle, the handle comprising an electrical connector which is configured to receive, in a releasable manner, an electrically conductive component operable to be electrically coupled to an energy source for generating radiofrequency energy; and wherein the integral puncturing distal end is an electrode for delivering radiofrequency energy to a tissue wherein the radiofrequency energy is supplied to the electrode by the metal tube.
2. The electrosurgical device of claim 1, wherein the metal tube defines a lumen, the handle includes a fluid connector for connecting the lumen to a source of fluid, and the integral puncturing distal end of the electrically conductive elongate member defines a distal aperture which is in fluid communication with the lumen.
3. The electrosurgical device of claim 1, wherein the electrical connector is electrically coupled to the electrically conductive elongate member through the handle, and the handle comprises a conductive wire for electrically coupling the electrical connector to the electrically conductive elongate member.
4. The electrosurgical device of claim 1, wherein the electrical connector comprises a jack for receiving the electrically conductive component, and a conductive wire extends from the handle and the jack is electrically connected to a distal end thereof such that the conductive wire electrically couples the jack to the handle.
5. The electrosurgical device of claim 1, wherein a force transmitting portion extends between the distal portion of the electrosurgical device and the proximal portion of the electrosurgical device, and the force transmitting portion has a flexural rigidity of at least about 0.016 Nm2.
6. The electrosurgical device of claim 1, wherein the handle comprises a hub.
7. The electrosurgical device of claim 6, wherein the puncturing distal end includes an electrode for delivering energy to a tissue.
8. The electrosurgical device of claim 6, wherein the electrically conductive elongate member defines a lumen, the hub includes a fluid connector for connecting the lumen to a source of fluid, and the integral puncturing distal end of the electrically conductive elongate member defines a distal aperture which is in fluid communication with the lumen.
9. The electrosurgical device of claim 6, further comprising a conductive wire for electrically coupling the electrical connector to the electrically conductive elongate member.
10. The electrosurgical device of claim 6, wherein the electrical connector comprises a jack for receiving the electrically conductive component, and a conductive wire extends from the hub and the jack is electrically connected to a distal end thereof such that the conductive wire electrically couples the jack to the hub.
11. The electrosurgical device of claim 6, wherein a force transmitting portion extends between a distal portion of the electrosurgical device and a proximal portion of the electrosurgical device, and the force transmitting portion has a flexural rigidity of at least about 0.016 Nm2.
12. A transseptal puncturing device comprising an electrically conductive elongate member which is a metal tube and an electrode emitting radiofrequency energy for radiofrequency perforation, the electrode formed integrally at a puncturing distal end of the metal tube for perforation to tissue, the transseptal puncturing device further including an electrical connector configured to receive, in a releasable manner, an electrically conductive component operable to be electrically coupled to an energy source.
13. The transseptal puncturing device of claim 12, wherein the metal tube defines a lumen and the transseptal puncturing device further comprises a handle which includes a fluid connector for connecting the lumen to a source of fluid, and a distal portion of the transseptal puncturing device defines a distal aperture in fluid communication with the lumen.
14. The transseptal puncturing device of claim 13, wherein the transseptal puncturing device includes an electrical insulation extending proximally from the electrode, the electrical insulation surrounding the metal tube.
15. The transseptal puncturing device of claim 12, wherein a distal tip of the transseptal puncturing device is substantially atraumatic.
16. The transseptal puncturing device of claim 12, wherein the electrical connector is electrically coupled to the electrically conductive elongate member, and a conductive wire electrically couples the electrical connector to the electrically conductive elongate member.
17. The transseptal puncturing device of claim 12, wherein the electrical connector comprises a jack for receiving the electrically conductive component.
18. A method of using a transseptal puncturing device, wherein the transseptal puncturing device comprises an elongate member which is electrically conductive, an electrical connector in electrical communication with the elongate member, and an electrode emitting radiofrequency energy for radiofrequency perforation, the electrode formed integrally at a puncturing distal end of the elongate member, and the method comprises the steps of (1) connecting an electrically conductive component, which is in electrical communication with a source of energy, to the electrical connector, and (2) delivering radiofrequency energy through the electrode to a tissue to puncture the tissue.
19. The method of claim 18, further comprising a step (3) disconnecting the electrically conductive component from the electrical connector.

CROSS-REFERENCES TO RELATED APPLICATIONS

This application is a continuation-in-part of U.S. application Ser. No. 14/222,909, filed on Mar. 24, 2014, now U.S. Pat. No. 10,493,259, which is a continuation-in-part of U.S. application Ser. No. 13/468,939, filed on May 10, 2012, now U.S. Pat. No. 8,679,107, which is a divisional application of, and claims priority from, U.S. application Ser. No. 11/905,447, filed on Oct. 1, 2007, now U.S. Pat. No. 8,192,425, which claims the benefit of: U.S. provisional application No. 60/827,452, filed on Sep. 29, 2006, and U.S. provisional application No. 60/884,285, filed on Jan. 10, 2007, all of which are incorporated by reference herein in their entirety.

US Referenced Citations (312)

Number	Name	Date	Kind
175254	Oberly	Mar 1876	A
827626	Gillet	Jul 1906	A
848711	Weaver	Apr 1907	A
1072954	Junn	Sep 1913	A
1279654	Charlesworth	Sep 1918	A
1918094	Geekas	Jul 1933	A
1996986	Weinberg	Apr 1935	A
2021989	De Master	Nov 1935	A
2146636	Lipchow	Feb 1939	A
3429574	Williams	Feb 1969	A
3448739	Stark et al.	Jun 1969	A
3575415	Fulp et al.	Apr 1971	A
3595239	Petersen	Jul 1971	A
4129129	Amrine	Dec 1978	A
4244362	Anderson	Jan 1981	A
4401124	Guess et al.	Aug 1983	A
4639252	Kelly et al.	Jan 1987	A
4641649	Walinsky et al.	Feb 1987	A
4669467	Willett et al.	Jun 1987	A
4682596	Bales et al.	Jul 1987	A
4790311	Ruiz	Dec 1988	A
4790809	Kuntz	Dec 1988	A
4793350	Mar et al.	Dec 1988	A
4807620	Strul et al.	Feb 1989	A
4832048	Cohen	May 1989	A
4840622	Hardy	Jun 1989	A
4863441	Lindsay et al.	Sep 1989	A
4884567	Elliott et al.	Dec 1989	A
4892104	Ito et al.	Jan 1990	A
4896671	Cunningham et al.	Jan 1990	A
4928693	Goodin et al.	May 1990	A
4936281	Stasz	Jun 1990	A
4960410	Pinchuk	Oct 1990	A
4977897	Hurwitz	Dec 1990	A
4998933	Eggers et al.	Mar 1991	A
5006119	Acker	Apr 1991	A
5019076	Yamanashi et al.	May 1991	A
5047026	Rydell	Sep 1991	A
5081997	Bosley et al.	Jan 1992	A
5098431	Rydell	Mar 1992	A
5112048	Kienle	May 1992	A
5154724	Andrews	Oct 1992	A
5201756	Horzewski et al.	Apr 1993	A
5209741	Spaeth	May 1993	A
5211183	Wilson	May 1993	A
5221256	Mahurkar	Jun 1993	A
5230349	Langberg	Jul 1993	A
5281216	Klicek	Jan 1994	A
5300068	Rosar et al.	Apr 1994	A
5300069	Hunsberger	Apr 1994	A
5314418	Takano	May 1994	A
5318525	West et al.	Jun 1994	A
5327905	Avitall	Jul 1994	A
5364393	Auth et al.	Nov 1994	A
5372596	Klicek et al.	Dec 1994	A
5380304	Parker	Jan 1995	A
5397304	Truckai	Mar 1995	A
5403338	Milo	Apr 1995	A
5423809	Klicek	Jun 1995	A
5425382	Golden et al.	Jun 1995	A
5490859	Mische et al.	Feb 1996	A
5497774	Swartz	Mar 1996	A
5507751	Goode et al.	Apr 1996	A
5509411	Littmann et al.	Apr 1996	A
5540681	Strul et al.	Jul 1996	A
5545200	West et al.	Aug 1996	A
5555618	Winkler	Sep 1996	A
5571088	Lennox et al.	Nov 1996	A
5575766	Swartz et al.	Nov 1996	A
5575772	Lennox	Nov 1996	A
5599347	Hart et al.	Feb 1997	A
5605162	Mirzaee et al.	Feb 1997	A
5617878	Taheri	Apr 1997	A
5622169	Golden et al.	Apr 1997	A
5624430	Eton et al.	Apr 1997	A
5667488	Lundquist et al.	Sep 1997	A
5673695	McGee et al.	Oct 1997	A
5674208	Berg et al.	Oct 1997	A
5683366	Eggers et al.	Nov 1997	A
5720744	Eggleston et al.	Feb 1998	A
5741249	Moss et al.	Apr 1998	A
5766135	Terwilliger	Jun 1998	A
5779688	Imran et al.	Jul 1998	A
5810764	Eggers et al.	Sep 1998	A
5814028	Swartz et al.	Sep 1998	A
5830214	Flom	Nov 1998	A
5836875	Webster, Jr.	Nov 1998	A
5849011	Jones et al.	Dec 1998	A
5851210	Torossian	Dec 1998	A
5885227	Finlayson	Mar 1999	A
5888201	Stinson et al.	Mar 1999	A
5893848	Negus et al.	Apr 1999	A
5893885	Webster, Jr.	Apr 1999	A
5904679	Clayman	May 1999	A
5916210	Winston	Jun 1999	A
5921957	Killion et al.	Jul 1999	A
5931818	Werp et al.	Aug 1999	A
5944023	Johnson et al.	Aug 1999	A
5951482	Winston et al.	Sep 1999	A
5957842	Littmann et al.	Sep 1999	A
5964757	Ponzi	Oct 1999	A
5967976	Larsen et al.	Oct 1999	A
5989276	Houser et al.	Nov 1999	A
6007555	Devine	Dec 1999	A
6009877	Edwards	Jan 2000	A
6013072	Winston et al.	Jan 2000	A
6017340	Cassidy et al.	Jan 2000	A
6018676	Davis et al.	Jan 2000	A
6030380	Auth et al.	Feb 2000	A
6032674	Eggers et al.	Mar 2000	A
6048349	Winston et al.	Apr 2000	A
6053870	Fulton, III	Apr 2000	A
6053904	Scribner et al.	Apr 2000	A
6056747	Saadat	May 2000	A
6063093	Winston et al.	May 2000	A
6093185	Ellis et al.	Jul 2000	A
6106515	Winston et al.	Aug 2000	A
6106520	Laufer et al.	Aug 2000	A
6117131	Taylor	Sep 2000	A
6142992	Cheng et al.	Nov 2000	A
6146380	Racz et al.	Nov 2000	A
6155264	Ressemann et al.	Dec 2000	A
6156031	Aita et al.	Dec 2000	A
6171305	Sherman	Jan 2001	B1
6179824	Eggers et al.	Jan 2001	B1
6193676	Winston et al.	Feb 2001	B1
6193715	Wrublewski	Feb 2001	B1
6210408	Chandrasekaran et al.	Apr 2001	B1
6217575	Devore et al.	Apr 2001	B1
6221061	Engelson et al.	Apr 2001	B1
6228076	Winston et al.	May 2001	B1
6245054	Fuimaono et al.	Jun 2001	B1
6267758	Daw et al.	Jul 2001	B1
6283983	Makower	Sep 2001	B1
6292678	Hall et al.	Sep 2001	B1
6293945	Parins	Sep 2001	B1
6296615	Brockway et al.	Oct 2001	B1
6296636	Cheng et al.	Oct 2001	B1
6302898	Edwards	Oct 2001	B1
6304769	Arenson et al.	Oct 2001	B1
6315777	Comben	Nov 2001	B1
6328699	Eigler et al.	Dec 2001	B1
6360128	Kordis et al.	Mar 2002	B2
6364877	Goble et al.	Apr 2002	B1
6385472	Hall et al.	May 2002	B1
6394976	Winston et al.	May 2002	B1
6395002	Ellman et al.	May 2002	B1
6419674	Bowser et al.	Jul 2002	B1
6428551	Hall et al.	Aug 2002	B1
6450989	Dubrul et al.	Sep 2002	B2
6475214	Moaddeb	Nov 2002	B1
6485485	Winston et al.	Nov 2002	B1
6508754	Liprie et al.	Jan 2003	B1
6524303	Garibaldi	Feb 2003	B1
6530923	Dubrul et al.	Mar 2003	B1
6554827	Chandrasekaran et al.	Apr 2003	B2
6562031	Chandrasekaran	May 2003	B2
6562049	Norlander et al.	May 2003	B1
6565562	Shah et al.	May 2003	B1
6607529	Jones et al.	Aug 2003	B1
6632222	Edwards et al.	Oct 2003	B1
6639999	Cookingham et al.	Oct 2003	B1
6650923	Lesh et al.	Nov 2003	B1
6651672	Roth	Nov 2003	B2
6662034	Segner et al.	Dec 2003	B2
6663621	Winston et al.	Dec 2003	B1
6702811	Stewart et al.	Mar 2004	B2
6709444	Makower	Mar 2004	B1
6723052	Mills	Apr 2004	B2
6733511	Hall et al.	May 2004	B2
6740103	Hall et al.	May 2004	B2
6752800	Winston et al.	Jun 2004	B1
6755816	Ritter et al.	Jun 2004	B2
6811544	Schaer	Nov 2004	B2
6814733	Schwartz et al.	Nov 2004	B2
6820614	Bonutti	Nov 2004	B2
6834201	Gillies et al.	Dec 2004	B2
6842639	Winston et al.	Jan 2005	B1
6852109	Winston et al.	Feb 2005	B2
6855143	Davison et al.	Feb 2005	B2
6860856	Ward et al.	Mar 2005	B2
6869431	Maguire et al.	Mar 2005	B2
6911026	Hall et al.	Jun 2005	B1
6951554	Johansen et al.	Oct 2005	B2
6951555	Suresh et al.	Oct 2005	B1
6955675	Jain	Oct 2005	B2
6970732	Winston et al.	Nov 2005	B2
6980843	Eng et al.	Dec 2005	B2
7029470	Francischelli et al.	Apr 2006	B2
7056294	Khairkhahan et al.	Jun 2006	B2
7083566	Tornes et al.	Aug 2006	B2
7112197	Hartley et al.	Sep 2006	B2
7335197	Sage	Feb 2008	B2
7618430	Scheib	Nov 2009	B2
7651492	Wham	Jan 2010	B2
7666203	Chanduszko et al.	Feb 2010	B2
7678081	Whiting et al.	Mar 2010	B2
7682360	Guerra	Mar 2010	B2
7828796	Wong et al.	Nov 2010	B2
7900928	Held et al.	Mar 2011	B2
8192425	Mirza et al.	Jun 2012	B2
8257323	Joseph et al.	Sep 2012	B2
8388549	Paul et al.	Mar 2013	B2
8500697	Kurth et al.	Aug 2013	B2
11339579	Stearns	May 2022	B1
20010012934	Chandrasekaran et al.	Aug 2001	A1
20010021867	Kordis et al.	Sep 2001	A1
20020019644	Hastings et al.	Feb 2002	A1
20020022781	Mclntire et al.	Feb 2002	A1
20020022836	Goble et al.	Feb 2002	A1
20020035361	Houser et al.	Mar 2002	A1
20020087153	Roschak et al.	Jul 2002	A1
20020087156	Maguire et al.	Jul 2002	A1
20020111618	Stewart et al.	Aug 2002	A1
20020123749	Jain	Sep 2002	A1
20020147485	Mamo et al.	Oct 2002	A1
20020169377	Khairkhahan et al.	Nov 2002	A1
20020188302	Berg et al.	Dec 2002	A1
20020198521	Maguire	Dec 2002	A1
20030032929	McGuckin	Feb 2003	A1
20030040742	Underwood et al.	Feb 2003	A1
20030144658	Schwartz et al.	Jul 2003	A1
20030158480	Tornes et al.	Aug 2003	A1
20030163153	Scheib	Aug 2003	A1
20030225392	McMichael et al.	Dec 2003	A1
20040015162	McGaffigan	Jan 2004	A1
20040024396	Eggers	Feb 2004	A1
20040030328	Eggers et al.	Feb 2004	A1
20040044350	Martin et al.	Mar 2004	A1
20040073243	Sepetka et al.	Apr 2004	A1
20040077948	Violante et al.	Apr 2004	A1
20040116851	Johansen et al.	Jun 2004	A1
20040127963	Uchida	Jul 2004	A1
20040133113	Krishnan	Jul 2004	A1
20040133130	Ferry et al.	Jul 2004	A1
20040143256	Bednarek	Jul 2004	A1
20040147950	Mueller et al.	Jul 2004	A1
20040181213	Gondo	Sep 2004	A1
20040230188	Cioanta et al.	Nov 2004	A1
20050004585	Hall et al.	Jan 2005	A1
20050010208	Winston et al.	Jan 2005	A1
20050049628	Schweikert et al.	Mar 2005	A1
20050059966	McClurken et al.	Mar 2005	A1
20050065507	Hartley	Mar 2005	A1
20050085806	Auge et al.	Apr 2005	A1
20050096529	Cooper et al.	May 2005	A1
20050101984	Chanduszko et al.	May 2005	A1
20050119556	Gillies et al.	Jun 2005	A1
20050137527	Kunin	Jun 2005	A1
20050149012	Penny et al.	Jul 2005	A1
20050203504	Wham et al.	Sep 2005	A1
20050203507	Truckai et al.	Sep 2005	A1
20050261607	Johansen et al.	Nov 2005	A1
20050288631	Lewis et al.	Dec 2005	A1
20060041253	Newton et al.	Feb 2006	A1
20060074398	Whiting et al.	Apr 2006	A1
20060079769	Whiting et al.	Apr 2006	A1
20060079787	Whiting et al.	Apr 2006	A1
20060079884	Manzo et al.	Apr 2006	A1
20060085054	Zikorus	Apr 2006	A1
20060089638	Carmel et al.	Apr 2006	A1
20060106375	Werneth et al.	May 2006	A1
20060135962	Kick et al.	Jun 2006	A1
20060142756	Davies	Jun 2006	A1
20060189972	Grossman	Aug 2006	A1
20060241586	Wilk	Oct 2006	A1
20060247672	Vidlund et al.	Nov 2006	A1
20060264927	Ryan	Nov 2006	A1
20060276710	Krishnan	Dec 2006	A1
20070060879	Weitzner et al.	Mar 2007	A1
20070066975	Wong	Mar 2007	A1
20070118099	Trout	May 2007	A1
20070123964	Davies et al.	May 2007	A1
20070167775	Kochavi et al.	Jul 2007	A1
20070208256	Marilla	Sep 2007	A1
20070225681	House	Sep 2007	A1
20070270791	Wang et al.	Nov 2007	A1
20080039865	Shaher et al.	Feb 2008	A1
20080042360	Veikley	Feb 2008	A1
20080086120	Mirza et al.	Apr 2008	A1
20080097213	Carlson et al.	Apr 2008	A1
20080108987	Bruszewski et al.	May 2008	A1
20080146918	Magnin et al.	Jun 2008	A1
20080171934	Greenan et al.	Jul 2008	A1
20080208121	Youssef et al.	Aug 2008	A1
20080275439	Francischelli et al.	Nov 2008	A1
20090105742	Kurth et al.	Apr 2009	A1
20090138009	Viswanathan et al.	May 2009	A1
20090163850	Betts et al.	Jun 2009	A1
20090177114	Chin et al.	Jul 2009	A1
20090264977	Bruszewski et al.	Oct 2009	A1
20100087789	Leeflang et al.	Apr 2010	A1
20100125282	Machek et al.	May 2010	A1
20100168684	Ryan	Jul 2010	A1
20100179632	Bruszewski et al.	Jul 2010	A1
20100191142	Paul et al.	Jul 2010	A1
20100194047	Sauerwine	Aug 2010	A1
20110046619	Ducharme	Feb 2011	A1
20110152716	Chudzik et al.	Jun 2011	A1
20110160592	Mitchell	Jun 2011	A1
20110190763	Urban et al.	Aug 2011	A1
20120232546	Mirza et al.	Sep 2012	A1
20120265055	Melsheimer et al.	Oct 2012	A1
20120330156	Brown et al.	Dec 2012	A1
20130184551	Paganelli et al.	Jul 2013	A1
20130184735	Fischell et al.	Jul 2013	A1
20130282084	Mathur et al.	Oct 2013	A1
20140206987	Urbanski et al.	Jul 2014	A1
20140296769	Hyde et al.	Oct 2014	A1
20160220741	Garrison et al.	Aug 2016	A1
20190021763	Zhou et al.	Jan 2019	A1
20190247035	Gittard et al.	Aug 2019	A1

Foreign Referenced Citations (28)

Number	Date	Country
0192724	Sep 1986	EP
0315730	May 1989	EP
1169976	Jan 2002	EP
1474203	Nov 2004	EP
1920724	May 2008	EP
1943974	Jul 2008	EP
2437058	Oct 2007	GB
07-303703	Nov 1995	JP
9320747	Oct 1993	WO
9856324	Dec 1998	WO
0019917	Apr 2000	WO
0033909	Jun 2000	WO
0051511	Sep 2000	WO
0117600	Mar 2001	WO
0193939	Dec 2001	WO
0258780	Aug 2002	WO
0294334	Nov 2002	WO
0368311	Aug 2003	WO
2004026131	Apr 2004	WO
2004026134	Apr 2004	WO
2004039433	May 2004	WO
2004064657	Aug 2004	WO
2005046487	May 2005	WO
2006039531	Apr 2006	WO
2007082343	Jul 2007	WO
2010078151	Jul 2010	WO
2013101632	Jul 2013	WO
2013179103	Dec 2013	WO

Non-Patent Literature Citations (63)

Entry
Medtronic Inc. “http://www.medtronic.com/epsystems/diagnostic.sub.—catheters.html”. Diagnostic Catheters. 7 pages (Date of Printing—Apr. 2005).
N Shimko, P. Savard, K Shah. “Radio frequency perforation of cardiac tissue: modeling and experimental results”. Med. Biol. Eng. Comput. 38:575-582 (2000).
Patent Cooperation Treaty, International Preliminary Report on Patentability, International Application No. PCT/IB2015/052118, dated Sep. 27, 2016.
Patent Cooperation Treaty, International Search Report for International Application No. PCT/IB2015/052118, dated Jun. 26, 2015.
Pressure Products, Inc. http://www.pressure-products.com/Downloads/Education.sub.—PDFs/Using.sub-.—CSG.sub.—v2.pdf. 4 pages. 2005.
Shyam S. Kothari, Sanjeev K. Sharma, Nitish Naik; Radiofrequency Perforation for Pulmonary Atresia and Intact Ventricular Septum; Indian Heart J Jan.—Feb. 2004;56(1):50-3 (Actual publication after Feb. 2004).
Suhonen M. et al. Recanalization of arterial occlusions using a specially designed steering catheter. European Radiology: 2, 264-265(1992).
Supplementary European Search Report, EP 15 76 8911, dated Nov. 1, 2017.
Szili-Torok, T et al. (2001) Transseptal Left Heart Catherisation Guided by Intracardiac Echocardiography, Heart 86:e11.
T Abdel-Massih, Y Boudjemline, P Bonhoeffer. “Unusual Interventional management in an adult with tetralogy of Fallot”. Cardiol Young 13(2):203-205 (Apr. 2003).
T Humpl, B Soderberg, BW McCrindle, DG Nykanen, RM Freedom, WG Williams, LN Benson. “Percutaneous Balloon Valvotomy in Pulmonary Atresia with Intact Ventricular Septum: Impact on Patient Care”. Circulation. 108(7): 826-832 (Aug. 2003).
Timothy A.M. Chuter, “Branched and Fenestrated Stent Grafts for Endovascular Repair of Thoracic Aortic Aneurysms”, Oct. 27, 2005, pp. 111A-115A, vol. 43, No. A, Publisher: The Society for Vascular Sugery, Published in U.S.
Tsung O. Cheng. “All Roads Lead to Rome:Transjugular or Transfemoral Approach to Percutaneous Transseptal Balloon Mitral Valvuloplasty?”. Catheterization and Cardiovascular Interventions 59:266-267 (2003).
Abstract of European Patent No. 0315730 to Osypka. May 1989.
Abstract of Leonard W.H. Tse et al., “In Vivo Antegrade Fenestration of Abdominal Aortic Stent-Grafts”, “Journal of Endovascular Therapy”, Apr. 2007, pp. 158-167, vol. 14, No. 2, Publisher: Journal of Endovascular Therapy, Published in: U.S.
Abstract of Richard G. McWilliams et al., “In Situ Stent-Graft Fenestration to Preserve the Left Subclavian Artery”, “Journal of Endovascular Therapy”, Apr. 2004, pp. 170-174, vol. 11, No. 2, Publisher: Journal of Endovascular Therapy, Published in: U.S.
Abstract of Richard G. McWilliams et al., “Retrograde Fenestration of Endoluminal Grafts From Target Vessels: Feasibility, Technique, and Potential Usage”, “Journal of Endovascular Therapy”, Oct. 2003, pp. 946-952, vol. 10, No. 5, Publisher: Journal of Endovascular Therapy, Published in: U.S.
Benson, Lee N., David Nykanen, Amanda Collison, “Radiofrequency Perforation in the Treatment of Congenital Heart Disease”. Catherizations and Cardiovascular Interventions; 56: 72-82, 2002.
Boston Scientific Corporation “http://www.bostonscientific.com/med.sub.—specialty/deviceDetail.jsp7tas-k=tskBasicDevice.jsp&sectionld=4&relld=2,74,75,76&deviceld=11026&uniqueID=-MPDB2799”. PT2 Guide Wire. 2 pages (Date of printing—Jun., 2005).
Boston Scientific Corporation. “http://www.bostonscientific.com/med.sub.—specialty/deviceDetail.jsp?tas-k=tskBasicDevice.jsp&sectionid=4&relld=1,20,21,22&deviceid=488&uniqueID=MP- DB58”. Explorer ST Catheters. 2 pages. (Date or printing—Jun., 2005).
Brendan M. Stanley et al., “Fenestration in Endovascular Grafts for Aortic Aneurysm Repair: New Horizons for Preserving Blood Flow in Branch Vessels”, “Journal of Endovascular Therapy”, Feb. 2001, pp. 16-24, vol. 8, Publisher: Journal of Endovascular Therapy, Published in: U.S.
C.R. Conti. “Transseptal Left Heart Catheterization for Radiofrequency Ablation of Accessory Pathways”. Clin. Cardiel. 16, 367-368 (1993).
CA Pedra, LN De Sousa, SR Pedra, WP Ferreira, SL Braga, CA Esteves, MV Santant, JE Sousa, VF Fontes. “New Percutaneous Techniques for Perforating the Pulmonary Valve in Pulmonary Atresia with Intact Ventricular Septum”. Arq. Bras Cariol. 77(5):471-478 (2001).
CA Pedra, LN de Sousa, SR Pedra, WP Ferreira, SL Braga, CA Esteves, MV Santant, JE Sousa, VF Fontes. “New Percutaneous Techniques for Perforating the Pulmonary Valve in Pulmonary Atresia with Intact Ventricular Septum”. Arq. Bras Cariol. 77(5):479-486 Nov. 2001.
CA Pedra, RM Filho, RS Arrieta, R Tellez, VF Fontes. “Recanalization of a discrete atretic right pulmonary artery segment with a new radiofrequency system”. Catheter Cardiovasc. Interv. 60(1):82-87 (Sep. 2003).
Carlos A.C. Pedra Luciano N.L. De Sousa, Simone R.F.F. Pedra, Waldinai P. Ferreira, Sergio L.N. Braga, Cesar A. Esteves, Maria Virginia T. Santana, J. Eduardo Sousa, Valmir F. Fontes; New Percutaneous Techniques for Perforating the Pulmonary Valve in Pulmonary Atresia with Intact Ventricular Septum; Arq Bras Cardiol. Nov. 2001;77(5):471-86.
Christodoulos Stefanadis. “Retrograde Nontransseptal Balloon Mitral Valvuloplasty: Immediate Results and Intermediate Long-Term Outcome in 441 Cases—A Multicentre Experience”. Journal of the American College of Cardiology. 32(4): 1009-16 (1998).
Christophe Fink, Mattias Peuster, Harald Bertram, Gerd Hausdorf; Transcatheter Recanalization of the Left Main Pulmonary Artery After Four Years of Complete Occlusion; Catheterization and Cardiovascular Interventions Jan. 2004;2(1):117-26.
Conti “finite element analysis of self-expanding braided wirestent” 2006-2007.
Conti C. R., “Transseptal Left Heart Catheterization for Radiofrequency Ablation of Accessory Pathways”. Clinical Cardiology; 16: 367-368, 1993.
Daniel S. Levi, Juan C. Alejos, John W. Moore; Future of Interventional Cardiology in Pediatrics; Current Opinion in Cardiology Mar. 2003;18(2):79-90.
DG Nykanen, J Phikala, GP Taylor, LN Benson. “Radiofrequency assisted perforation of the atrial septum in a swine model: feasibility, biophysical and histological characteristics”, Circulation. 100(Suppl 1):I-804 (1999).
Edward B. Diethrich, “Side Branch Preservation During Endovascular Aortic Aneurysm Repair”, “Journal of Endovascular Therapy”, Feb. 2001, pp. 1-2, vol. 8, Publisher: Journal of Endovascular Therapy, Published in: U.S.
F Godart, C Francart, GM Breviere, C Rey. “Pulmonary vavulotomy with the Nykanen radiofrequency guide in pulmonary atresia with intact interventricular septum”, Arch Mal Coeur Vaiss. 96(5):517-520 (May 2003), Article is in French with an English summary.
Fink, Peuster, Bertram, Hausdorf. Transcatheter Recanalization of the Left Main Pulmonary Artery after Four Years of Complete Occlusion. Catheterization and Cardiovascular Interventions. May 2001;53(1):81-4.
First Office Action for Chinese Application, Application/Patent No. 2015800262435, Issue Serial No. 2018122001954460, dated Dec. 25, 2018.
Frank R. Arko III, “In Pursuit of an Off-the Shelf Fenestrated Stent-Graft: Radiofrequency Perforation for In Vivo Antegrade Fenestration”, “Journal of Endovascular Therapy”, Apr. 2010, pp. 199-200, vol. 17, No. 2, Publisher: Journal of Endovascular Therapy, Published in: U.S.
G Hausdorf, I Schulze-Neick, Pe Lange; Radiofrequency-assisted “reconstruction” of the Right Ventricular Outflow Tract in Muscular Pulmonary Atresia with Ventricular Septal Defect; British Heart Journal, Apr. 1993:69(4):343-6.
G Veldtman, A Peirone, LN Benson. “Radiofrequency perforation of the atrial septum: Preliminary experimental evaluation and development” Pics VII Abstracts. Catheter Cardiovasc Interv. 60(1):132 (Sep., 2003).
George Joseph, Dibya K. Baruah, Sajy V. Kuruttukulam, Sunil Thomas Chandy, Shanker Krishnaswami. “Transjugular Approach to Transseptal Balloon Mitral Valvuloplasty”. Catheterization and Cardiovascular Diagnosis 42:219-226 (1997).
George Joseph, G. Rajendiran, K. Abhaichand Rajpal. “Transjugular Approach to Concurrent Mitral-Aortic and Mitral-Tricuspid Balloon Valvuloplasty”. Catheterization and Cardiovascular Interventions 49:335-341 (2000).
George Joseph, K.P. Suresh Kumar, Paul V. George, Subodh Dhanawade. “Right Internal Jugular Vein Approach as an Alternative in Balloon Pulmonary Valvuloplasty”. Catheterization and Cardiovascular Interventions 46:425-429 (1999).
George Joseph, Oommen K. George, Asishkumar Mandalay, Sunil Sathe. “Transjugular Approach to Balloon Mitral Valvuloplasty Helps Overcome Impediments Caused by Anatomical Alterations”. Catheterization and Cardiovascular Interventions 57:353-362 (2002).
Gero Hausdorf, Martin Schneider. Peter Lange; Catheter Creation of an Open Outflow Tract in Previously Atretic Right Ventricular Outflow Tract Associated with Ventricular Septal Defect; The American Journal of Cardiology, Aug. 1, 1993;72(3):354-6.
Gideon J. Du Marchie Sarvaas, Kalyani R. Trivedi, Lisa K. Hornberger, K. Jin Lee, Hoel A. Kirsh, Lee N. Benson. “Radiofrequency-Assisted Atrial Septoplasty for an Intact Atrial Septum in Complex Congenital Heart Disease”. Catheterization and Cardiovascular Interventions; 56: 412-415 (2002).
H Justino, LN Benson, DG Nykanen. “Transcatheter Creation of an Atrial Septal Defect Using Radiofrequency Perforation”. Catheter Cardiovasc Interv. 54(1):83-87 (Sep. 2001).
Hector Biddogia, Juan P. Maciel, Jose A. Alvarez et al. “Transseptal Left Heart Catheterization: Usefulness of the Intracavitary Electrocardiogram in the Localization of the Fossa ovalis”. Catheterization and Cardiovascular Diagnosis 24: 221-225 (1991).
Holzer, Hardin, Hill, Chisolm, Cheatham. Radiofrequency Energy—A Multi-Facetted Tool for the Congenital Interventionist. Congenital Cardiology Today. Jun. 2006; 4(6): 1-.
Hugh Calkins, Yoon-Nyun Kim, Steve Schmaltz, Joao Sousa, Rafel El-Atassi, Angel Leon, Alan Kadish, Jonathan J. Langberg, Fred Morady; Electrogram Criteria for Identification of Appropriate Target Sites for Radiofrequency Catheter Ablation of Accessory Atrioventricular Connections; Feb. 1992;85(2):565-73.
HW Kort, DT Balzer. “Radiofrequency perforation in the treatment of acquired left pulmonary atresia following repair of teraligy of Fallot”. Catheter Cardiovasc Interv. 60(1):79-81 (Sep. 2003).
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2007/061203, dated Oct. 26, 2007, 8 pages.
IntraLuminal Therapeutics, Inc. “http://www.intraluminal.com/products/catheter.html”. Safe Cross Support Catheter. 1 page. (Date of Printing—Jun. 2005).
J. E Della, “Notice of Allowance in the case of U.S. Appl. No. 11/520,754”, dated Jul. 2, 2010.
J. Thompson Sullebarger, Humberto Coto, Enrique Lopez, Dany Sayad, Hector L. Fontanet. “Transjugular Percutaneous Inoue Balloon Mitral Commissurotomy in a Patient With Inferior Vena Cava Obstruction After Liver Transplantation”. Catheterization and Cardiovascular Interventions 59:261-265 (2003).
John Lennon Anderson et al., “Endoluminal Aortic Grafting with Renal and Superior Mesenteric Artery Incorporation by Graft Fenestration”, “Journal of Endovascular Therapy”, Feb. 2001, pp. 3-15, No. 8, Publisher: Journal of Endovascular Therapy, Published in: U.S.
Johnson & Johnson Gateway, LLC. “http://www.jnjgateway.com/home.jhtml;jsessionid=JNSFHTWOAOIC0CQPCCECPJYK-B2IIWNSC?icc=USENG&page=viewContent&contentid=IC0de00100000524&nodekey=/Pr-od.sub.—Info/Specialty/Cardiovascular.sub.—and.sub.—Thoracic/Cardiac.su-b.—Diagnosis.sub.—lnterventions/Diagnostic.sub.—Wires&.sub.—requestid=- 228905”, Diagnostic Guidewires, 4 pages.
Johnson & Johnson Gateway, LLC. “http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentld=lc0de00100001435&nodekey=/Prod.sub.—info/Specialty/Arrhythmia.sub.—Management/Electrophysiology/EPsub.—Diagnostic.su- b.—Catheters”. EP Diagnostic Catheters, 2 pages (Date of printing—Jun., 2005).
Justino, Henri, Lee N. Benson, David G. Nykanen. “Transcatheter Creation of an Atrial Septal Defect Using Radiofrequency Perforation”. Catheterization and Cardiovascular Interventions. 56:412-415 (2002).
Kamal K. Sethi, Jagdish C. Mohan. “Editiorial Comment: Transseptal Catheterization for the Electrophysiologist: Modification with a ‘View’”. Journal of Interventional Cardian Physiology. 5, 97-99, 2001.
Kamal K. Sethi, Jagdish C. Mohan. “Editorial Comment: Transseptal Catheterization for the Electrophysiologist: Modification with a ‘View’”. Journal of Interventional Cardiac Physiology. 5, 97-99, 2001.
Lake Region Manufacturing, Inc. “http://www.lakergn.com/jmc.htm”. Paragon Guidewire. 2 pages (Date of Printing—Jun. 2005).
Leonard W. H. Tse et al., “Radiofrequency Perforation System for an In Vivo Antegrade Fenestration of Aortic Stent-Grafts”, “Journal of Endovascular Therapy”, Apr. 2010, pp. 192-198, vol. 17, No. 2, Publisher: Journal of Endovascular Therapy, Published in: U.S.
Lepage, Lewis, Ruiz, Yamanishi, Padron, Hood. Angiopyroplasty using Electromagnetically Induced Focused Heat. Angiology. Jul. 1987;38(7):520-3.

Related Publications (1)

	Number	Date	Country
	20190374281 A1	Dec 2019	US

Provisional Applications (2)

	Number	Date	Country
	60884285	Jan 2007	US
	60827452	Sep 2006	US

Divisions (1)

	Number	Date	Country
Parent	11905447	Oct 2007	US
Child	13468939		US

Continuation in Parts (2)

	Number	Date	Country
Parent	14222909	Mar 2014	US
Child	16532980		US
Parent	13468939	May 2012	US
Child	14222909		US

Electrosurgical device

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Term Extension

Abstract